<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1477902</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Rat models of postintracerebral hemorrhage pneumonia induced by nasal inoculation with <italic>Klebsiella pneumoniae</italic> or intratracheal inoculation with LPS</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Ruihua</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1731794"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Gan</surname>
<given-names>Changlian</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mao</surname>
<given-names>Rui</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/571397"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Ru</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/477708"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Geng</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/716257"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xiong</surname>
<given-names>Tianqin</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1888263"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Guo</surname>
<given-names>Jianwen</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Research Team of Prevention and Treatment of Cerebral Hemorrhage Applying Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>School of Traditional Dai Medicine, West Yunnan University of Applied Science</institution>, <addr-line>Xishuangbanna</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>The Second Clinical College of Guangzhou University of Chinese Medicine</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Bioinformatics, State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau</institution>, <addr-line>Macao</addr-line>, <country>Macao SAR, China</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Laboratory Animal Center, Guangzhou University of Chinese Medicine</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>State Key Laboratory of Traditional Chinese Medicine Syndrome, Department of Neurology, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Xiao-Yi Xiong, Chengdu University of Traditional Chinese Medicine, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Jia Yin, Southern Medical University, China</p>
<p>Michelle Darrieux, Sao Francisco University, Brazil</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Geng Li, <email xlink:href="mailto:lg@gzucm.edu.cn">lg@gzucm.edu.cn</email>; Tianqin Xiong, <email xlink:href="mailto:xiongtq020@gzucm.edu.cn">xiongtq020@gzucm.edu.cn</email>; Jianwen Guo, <email xlink:href="mailto:drguo@gzucm.edu.cn">drguo@gzucm.edu.cn</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>01</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1477902</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>08</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Wang, Gan, Mao, Chen, Yan, Li, Xiong and Guo</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Wang, Gan, Mao, Chen, Yan, Li, Xiong and Guo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>A stable and reproducible experimental bacterial pneumonia model postintracerebral hemorrhage (ICH) is necessary to help investigating the pathogenesis and novel treatments of Stroke-associated pneumonia (SAP).</p>
</sec>
<sec>
<title>Aim</title>
<p>To establish a Gram-negative bacterial pneumonia-complicating ICH rat model and an acute lung injury (ALI)-complicating ICH rat model.</p>
</sec>
<sec>
<title>Methods</title>
<p>We established two standardized models of post-ICH pneumonia by nasal inoculation with <italic>Klebsiella pneumoniae</italic> (<italic>Kp</italic>) or intratracheal inoculation with lipopolysaccharide (LPS). Survival and neurological scores were monitored. Magnetic resonance imaging was performed to evaluate hematoma volume. Abdominal aortic blood was collected for leukocyte counting, serum was isolated to determine concentrations of S100&#x3b2; and proinflammatory cytokines using ELISAs. Histopathological changes of brain, lung and gut were assessed using hematoxylin&#x2212;eosin staining. Lung was isolated for immunofluorescence staining for myeloperoxidase (MPO). Bronchoalveolar lavage fluid was collected for leukocyte counting, and supernatant was prepared to measure MPO activity. Ileum was isolated for immunofluorescence staining for tight junction proteins ZO-1 and &#x3b3;&#x3b4; TCRs/IL-17A and for Alcian blue&#x2013;nuclear fast red staining of acidic mucins. Feces were collected, 16S rRNA sequencing, untargeted metabolomics and Spearman&#x2019;s correlation analyses were performed to explore changes of gut microbiota, metabolites and their interactions.</p>
</sec>
<sec>
<title>Results</title>
<p>In <italic>Kp</italic>-induced bacterial pneumonia-complicating ICH rats, we demonstrated that <italic>Kp</italic> challenge caused more severe neurological deficits, brain damage, neuroinflammation, and aggravated pneumonia and lung injury. Disruptions of the intestinal structure and gut barrier and the reductions of the protective intestinal IL-17A-producing &#x3b3;&#x3b4;T cells were also observed. <italic>Kp</italic> challenge exacerbated the gut microbiota dysbiosis and fecal metabolic profile disorders, which were characterized by abnormal sphingolipid metabolism especially elevated ceramide levels; increased levels of neurotoxic quinolinic acid and an upregulation of tryptophan (Trp)&#x2013;serotonin&#x2013;melatonin pathway. Spearman&#x2019;s correlation analyses further revealed that the reduction or depletion of some beneficial bacteria, such as <italic>Allobaculum</italic> and <italic>Faecalitalea</italic>, and the blooming of some opportunistic pathogens, such as <italic>Turicibacter</italic>, <italic>Dietzia</italic>, <italic>Corynebacterium</italic> and <italic>Clostridium_sensu_stricto_1</italic> in <italic>Kp</italic>-induced SAP rats were associated with the disordered sphingolipid and Trp metabolism. Using an LPS-induced ALI complicating ICH model, we also characterized SAP-induced brain, lung and gut histopathology injuries; peripheral immune disorders and intense pulmonary inflammatory responses.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>These two models may be highly useful for investigating the pathogenesis and screening and optimizing potential treatments for SAP. Moreover, the differential genera and sphingolipid or Trp metabolites identified above seem to be promising therapeutic targets.</p>
</sec>
</abstract>
<kwd-group>
<kwd>intracerebral hemorrhage</kwd>
<kwd>stroke-associated pneumonia</kwd>
<kwd>
<italic>Klebsiella pneumoniae</italic>
</kwd>
<kwd>lipopolysaccharide</kwd>
<kwd>16S rRNA sequencing and untargeted metabolomics</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Special Project for Research and Development in Key areas of Guangdong Province<named-content content-type="fundref-id">10.13039/501100015956</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Guangzhou Municipal Science and Technology Bureau<named-content content-type="fundref-id">10.13039/501100020084</named-content>
</contract-sponsor>
<counts>
<fig-count count="8"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="101"/>
<page-count count="24"/>
<word-count count="12708"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Multiple Sclerosis and Neuroimmunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Stroke is the second leading cause of death and the third leading cause of death and disability worldwide (<xref ref-type="bibr" rid="B1">1</xref>). Intracerebral hemorrhage (ICH) accounts for 9&#x2013;27% of stroke cases (<xref ref-type="bibr" rid="B2">2</xref>) and is the most lethal and least treatable subtype (<xref ref-type="bibr" rid="B3">3</xref>). Stroke-associated pneumonia (SAP) is one of the major complications after stroke and is associated with significantly increased health care costs, poor functional outcomes and mortality (<xref ref-type="bibr" rid="B4">4</xref>). The incidence of SAP in ICH patients continues to be high, ranging from 14.3&#x2013;31.1% (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). Currently, the clinical strategies used to prevent or treat SAP are based on the use of antibiotics. Major clinical trials have shown that prophylactic antibiotics have no beneficial effects on functional outcomes or mortality (<xref ref-type="bibr" rid="B7">7</xref>). Despite being effective for the treatment of infections, they need to be used cautiously because of potentially harmful adverse effects and an alarming increase in antibiotic-resistant strains of bacteria (<xref ref-type="bibr" rid="B8">8</xref>). Thus, more effective therapeutic strategies that target the underlying pathogenesis of SAP are urgently needed.</p>
<p>Animal models are necessary to help reveal the pathogenesis and validate new interventions that might alleviate SAP. Various experimental models of SAP have been developed in practice to mimic human clinical scenarios. Mice can develop spontaneous bacterial infections and pneumonia due to stroke-induced immunodeficiency, as well as the translocation of the gut microbiota to the lungs (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>). However, some studies have reported conflicting results (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Moreover, the incidence and severity of spontaneous pneumonia vary depending on genetic background (<xref ref-type="bibr" rid="B14">14</xref>), environmental factors such as animal housing facility conditions that may affect the microbiota and thus systemic immune responses (<xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>), and the choice of stroke model (<xref ref-type="bibr" rid="B18">18</xref>). A model inducing standardized bacterial pneumonia is desirable to increase the reproducibility and predictability of SAP studies. Currently, intranasally inoculated <italic>Streptococcus pneumoniae</italic> (<italic>Sp</italic>) or <italic>Klebsiella pneumoniae</italic> (<italic>Kp</italic>) (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>) or intratracheally injected <italic>Sp</italic>-induced bacterial pneumonia complicating ischemic stroke models (<xref ref-type="bibr" rid="B21">21</xref>) have been successfully established. However, a stable and reproducible experimental bacterial pneumonia model post-ICH is not currently available.</p>
<p>A systematic review of 15 studies involving 7968 stroke patients suggested that aerobic Gram-negative bacilli (38%) and Gram-positive cocci (16%) were most frequently isolated from sputum, tracheal aspirate and blood cultures, with <italic>Enterobacteriaceae</italic> (<italic>Kp</italic>, <italic>Escherichia coli</italic>), <italic>Staphylococcus aureus</italic>, <italic>Pseudomonas aeruginosa</italic>, <italic>Acinetobacter baumannii</italic> and <italic>Sp</italic> identified as the most common organisms responsible for pneumonia complicating stroke (<xref ref-type="bibr" rid="B22">22</xref>).</p>
<p>Considering that <italic>Kp</italic> is the pathogen most frequently isolated from SAP, in this study, we established a Gram-negative bacterial pneumonia complicating ICH model via nasal inoculation with <italic>Kp</italic> after collagenase-induced ICH in rats (<xref ref-type="bibr" rid="B23">23</xref>). Since <italic>Kp</italic> is a biosafety level 2 (BSL-2) opportunistic pathogen associated with infections (<xref ref-type="bibr" rid="B24">24</xref>), the widespread use of a <italic>Kp</italic>-induced bacterial pneumonia complicating ICH model is limited because of biosafety concerns and the limited availability of high-level biosafety labs. Lipopolysaccharide (LPS), a key component of Gram-negative bacterial cell walls, has been extensively used to simulate Gram-negative bacterium-induced acute lung inflammation and lung injury (ALI) (<xref ref-type="bibr" rid="B25">25</xref>). Therefore, we further established LPS-induced ALI complicating ICH model via intratracheal inoculation with LPS after ICH. Using these two models, we characterized SAP&#x2212;induced brain, lung, and gut histopathological injuries and peripheral and pulmonary immune disorders. We further performed 16S ribosomal RNA (rRNA) sequencing, untargeted metabolomics and Spearman&#x2019;s correlation analyses to identify SAP-related gut microbial species, metabolites and functional pathways.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Animals</title>
<p>For Experiments 1, 3, and 4, male Sprague&#x2212;Dawley (SD) rats (200&#x2013;240 g, 8&#x2013;9 weeks old) of specific pathogen-free (SPF) grade were obtained from Guangdong Medical Laboratory Animal Center (Guangdong, China) and housed in the Laboratory Animal Center of Guangdong Provincial Hospital of Chinese Medicine under standard care conditions (temperature, 24 &#xb1; 2&#xb0;C; relative humidity, 60 &#xb1; 5%; normal day/night cycle, 12/12 h; with food and water available ad libitum). For Experiment 2, male SD rats (200&#x2013;240 g, 8&#x2013;9 weeks old) of SPF grade were obtained from ZhuHai Bestest Biotechnology Co., Ltd. (Guangdong, China) and housed in the Laboratory Animal Center of Guangzhou University of Chinese Medicine under standard care conditions. All animal experiments were performed according to the Guidelines for the Care and Use of Laboratory Animals of the National Institutes of Health and protocols approved by the Institutional Ethics Committee of Guangzhou University of Chinese Medicine or Guangdong Provincial Hospital of Chinese Medicine.</p>
</sec>
<sec id="s2_2">
<title>Study design</title>
<sec id="s2_2_1">
<title>Experiment 1</title>
<p>ICH models were induced by injecting different doses of type VII collagenase (Sigma&#x2212;Aldrich, USA) into the right caudate nucleus to investigate whether SD rats can develop secondary pulmonary infection and pneumonia after ICH. Twelve rats were randomly assigned to the following four groups (n=3 rats per group): the sham and 0.175 U, 0.35 U and 0.7 U type VII collagenase-induced ICH. At 7 days after ICH, brain and lung samples were collected to assess histopathological changes using hematoxylin&#x2212;eosin (H&amp;E) staining.</p>
</sec>
<sec id="s2_2_2">
<title>Experiment 2</title>
<p>Thirty-three rats were randomly assigned to the following three groups: the sham (n=10), ICH (n=9) and SAP (ICH <italic>+ Kp</italic>, n=14). Survival was monitored daily. The neurological score was recorded from Day 3 to Day 7 after ICH induction. At 7 days after ICH (4 days after <italic>Kp</italic> inoculation), serum was collected from the abdominal aortic blood to determine the concentration of S100&#x3b2; using ELISA. Histopathological changes in the brain, lung, ileum and colon were assessed via H&amp;E staining. Lung tissues were isolated for immunofluorescence staining for myeloperoxidase (MPO). Bronchoalveolar lavage fluid (BALF) supernatant was prepared for measurement of MPO activity. Ileum sample was isolated for immunofluorescence staining for the tight junction proteins zonula occluden-1(ZO-1) and &#x3b3;&#x3b4; T cell receptors (TCRs)/interleukin (IL)-17A and for Alcian blue&#x2013;nuclear fast red (AB-NFR) staining of acidic mucins. Fecal sample was collected before sacrifice, 16S rRNA sequencing, untargeted metabolomics and Spearman&#x2019;s correlation analyses were performed to explore the changes in the gut microbiota, metabolites and their interactions.</p>
</sec>
<sec id="s2_2_3">
<title>Experiment 3</title>
<p>Forty-five rats were randomly assigned to the following three groups (n=15 rats per group): the sham, 2 mg/kg LPS-SAP (ICH <italic>+</italic> 2 mg/kg LPS) and 3 mg/kg LPS-SAP (ICH <italic>+</italic> 3 mg/kg LPS) groups. At 4 days after ICH (1 day after LPS inoculation), serum was collected from the abdominal aortic blood to determine the concentrations of tumor necrosis factor-&#x3b1; (TNF-&#x3b1;), IL-1&#x3b2; and IL-6 using ELISAs. BALF was prepared for cell counting.</p>
</sec>
<sec id="s2_2_4">
<title>Experiment 4</title>
<p>Thirty rats were randomly assigned to the following two groups (n=15 rats per group): the sham and SAP (ICH <italic>+</italic> 3 mg/kg LPS). Survival, body weight and neurological scores were monitored daily. At 4 days after ICH (1 day after LPS inoculation), magnetic resonance imaging (MRI) was performed to detect the locations, boundaries and extent of the hematomas using susceptibility-weighted imaging (SWI) pulse sequences. Abdominal aortic blood was collected for leukocyte counting. Histopathological changes in the brain, lung and ileum were assessed via H&amp;E staining.</p>
</sec>
</sec>
<sec id="s2_3">
<title>Induction of experimental ICH</title>
<p>Our experimental ICH procedure is based on a previously described method reported by Rosenberg et&#xa0;al. (<xref ref-type="bibr" rid="B23">23</xref>) with some modifications. Briefly, after being anesthetized with pentobarbital sodium (40 mg/kg, 1%) via intraperitoneal injection, SD rats were fixed in a stereotactic apparatus (RWD, Life Science, China) in the prone position. A total of 0.5 U type VII collagenase (Sigma&#x2212;Aldrich, USA) prepared in 2 &#x3bc;L of TESCA buffer (Solarbio, China) containing 2.5 U/&#x3bc;L heparin sodium (Sigma&#x2212;Aldrich, USA) was stereotactically injected into the right basal ganglia within 5 minutes (coordinates, 3.0 mm right lateral to the bregma, 6 mm ventral relative to the skull surface) using a 10 &#x3bc;L microsyringe needle (Gaoge Industry and Trade Co., Ltd., Shanghai, China). The needle was left in place for 5 minutes (min) and then slowly withdrawn. The sham rats underwent the same surgical procedures without the injection of collagenase, instead, 2 &#x3bc;L of TESCA buffer containing 2.5 U/&#x3bc;L heparin sodium was injected. Zea-Longa scoring was performed to assess brain damage the next day. Rats with Zea-Longa scores ranging from 1&#x2013;3 were selected for nasal inoculation with <italic>Kp</italic> or intratracheal inoculation with LPS at 3 days after ICH.</p>
</sec>
<sec id="s2_4">
<title>Bacterial culture and nasal inoculation with <italic>Kp</italic>
</title>
<p>
<italic>K. pneumoniae</italic> K6 (American Type Culture Collection #700603) was grown from frozen stocks on Mueller&#x2212;Hinton (MH) agar plates (Solarbio, China) overnight at 37&#xb0;C. Colonies were inoculated into MH broth medium (Solarbio, China) and cultured with shaking overnight. Cultures were diluted in MH broth until they reached the mid-logarithmic growth phase (OD600 nm, 0.7). Bacteria were pelleted via centrifugation, washed twice with 0.9% saline and diluted to a final concentration of 2&#xd7;10<sup>6</sup> colony-forming units (CFUs)/ml. 50 &#x3bc;L of the bacterial suspension was slowly injected into each nostril of each SAP rat after anesthetizing them with pentobarbital sodium, and 50 &#x3bc;L of the 0.9% saline alone (control) was slowly injected into each nostril of each sham or ICH rat. After inoculation, the rats were maintained upright and rotated for 2 min so that the <italic>Kp</italic> was uniformly distributed into the lungs. The rats were placed under an infrared heating lamp until they recovered from anesthesia. The inoculated animals were housed separately from the 0.9% saline-only controls.</p>
</sec>
<sec id="s2_5">
<title>Intratracheal inoculation with LPS</title>
<p>The rats were anesthetized and placed in a supine position on a board. LPS (055:B5, Sigma, USA) was dissolved in 0.9% saline. 200 &#x3bc;L of LPS solution was injected into the trachea at a dosage of 2 mg/kg or 3 mg/kg using a 1 ml insulin syringe with a 29-gauge needle (BD, USA). After inoculation, the rats were kept upright and rotated for 2 min to ensure that the LPS was uniformly distributed into the lungs. The rats were placed under an infrared heating lamp until they recovered from anesthesia. The inoculated animals were housed separately from the 0.9% saline-only controls.</p>
</sec>
<sec id="s2_6">
<title>Neurological function evaluation</title>
<p>The modified neurological severity score (mNSS) was used to evaluate the neurological deficits of the ICH rats. mNSS consists of 4 subtests that assess motor, sensory, balance and reflex functions. Neurological function was graded on a scale of 0&#x2013;18. A higher score indicates worse neurological function (1&#x2013;6 indicates mild injury, 7&#x2013;12 indicates moderate injury, and 13&#x2013;18 indicates severe injury) (<xref ref-type="bibr" rid="B26">26</xref>). All tests were conducted by an investigator who was blinded to the experimental groups.</p>
</sec>
<sec id="s2_7">
<title>MRI examination and hematoma volume calculation</title>
<p>The MRI scans were performed using a 3.0-T MRI scanner system (MAGNETOM Prisma, Siemens Healthcare, Germany). After being deeply anesthetized, the rats were positioned prone with the head inside an 8-channel mouse coil (Chen Guang Medical Technologies Co., Ltd., Shanghai, China). SWI was acquired 4 days after ICH induction. The parameters are as follows: matrix, 192&#xd7;192; FOV, 60 mm &#xd7; 60 mm; TR, 30.0 ms; TE, 20.0 ms; flip angle, 15&#xb0;; slice thickness, 1.0 mm; and slice gap, 0.2 mm. The hematoma volume was calculated according to the Coniglobus formula, where V&#x2009;=&#x2009;a&#x2009;&#xd7;&#x2009;b&#x2009;&#xd7;&#x2009;c&#x2009;&#xd7;&#x2009;1/2 at the largest hematoma level (a indicates the longest diameter of hematoma, b indicates the longest diameter perpendicular to a, and c indicates the number of layers with bleeding&#x2009;&#xd7; slice thickness). All examinations and hematoma volume calculations were conducted by a qualified physician who was blinded to the experimental groups.</p>
</sec>
<sec id="s2_8">
<title>Histopathological changes in the brain, lung and gut tissues</title>
<p>Histopathological changes in the brain, lung and gut tissues were assessed via H&amp;E staining. The rats were deeply anesthetized and transcardially perfused with 200 mL of precooled 0.9% saline. The brain, lung, ileum and colon samples were isolated, fixed with 10% phosphate-buffered formalin, embedded in paraffin and sliced into 4&#x2212;&#x3bc;m thick sections. After deparaffinization, the tissue sections were stained with HE according to the manufacturer&#x2019;s instructions (Pinofei Biotechnology Co., Ltd., Wuhan, China). The sections were scanned with the PANNORAMIC MIDI II and viewed using SlideViewer (3DHISTECH, Hungary).</p>
</sec>
<sec id="s2_9">
<title>Immunofluorescence staining</title>
<p>As previously described, the paraffin-embedded tissues were sliced into 4&#x2212;&#x3bc;m thick sections. After deparaffinization and rehydration, the sections were immersed in 10 mM sodium citrate buffer (pH 6.0) (AR0024, Boster, Wuhan, China) for antigen retrieval by boiling in a microwave for 8 min, followed by an incubation in PBS supplemented with 0.3% Triton X-100 for 10 min and 10% goat serum (Sangon Biotech Co., Ltd., Shanghai, China) for 1 h at room temperature. For analysis of the expression of the tight junction protein ZO-1, ileum sections were subjected to an overnight incubation with a ZO-1 rabbit polyclonal antibody (1:300, Affinity, Cat# AF5145) at 4&#xb0;C in a humidified environment. For the analysis of the expression of MPO, lung sections were subjected to an overnight incubation with aMPO rabbit monoclonal antibody (1:100, Abcam, Cat# ab208670) at 4&#xb0;C in a humidified environment. The sections were subsequently washed with PBST and incubated with Alexa Fluor<sup>&#xae;</sup> 555-conjugated goat anti-rabbit IgG (H+L), F(ab&#x2019;)2 fragment (1:2000, Cell Signaling Technology, Cat# 4413S) at 37&#xb0;C for 1 h. The ileum sections were incubated with the following antibodies at room temperature for 2 h in a humidified environment to analyze the number of &#x3b3;&#x3b4; T cells and IL-17A expression: PE-conjugated mouse anti-rat &#x3b3;&#x3b4; T-cell receptor (1:15, BD Pharmingen&#x2122;, Cat#551802) and PE-Cyanine7-conjugated anti-rat IL-17A monoclonal antibody (1:15, eBioscience&#x2122;, Cat# 25-7177-82). Finally, the sections were stained with DAPI and mounted with antifade medium (Cat# S2110; Solarbio, Beijing, China). Representative images were captured with a fluorescence microscope (Eclipse TS100, Nikon, Japan). The images were semiquantitated using ImageJ version 1.51 (NIH, USA).</p>
</sec>
<sec id="s2_10">
<title>AB-NFR staining</title>
<p>AB-NFR staining was performed to analyze the expression of acidic mucins according to the manufacturer&#x2019;s instructions (Cat #C0155S, Beyotime Biotechnology, Haimen, China). Briefly, the paraffin-embedded ileum samples were sliced into 4&#x2212;&#x3bc;m thick sections. After deparaffinization, the sections were rehydrated through alcohol gradient washes, stained with an Alcian blue solution (pH 2.5) for 1 h in a humidified environment, rinsed with distilled water and stained with nuclear fast red solution (pH 2.5) for 5 min. The sections were then rinsed with distilled water again and gradually dehydrated by gradient alcohol. Finally, the sections were cleared in xylene and observed under an inverted microscope (Eclipse TS100, Nikon, Japan) after being sealed with neutral gum (Solarbio, Beijing, China). The relative density of positive area in AB-PAS staining was calculated using ImageJ version 1.51 (NIH, USA).</p>
</sec>
<sec id="s2_11">
<title>Routine blood testing</title>
<p>2 mL of abdominal aortic blood was collected from the rats in Experiment 4 into a 5 mL EDTA-K2 anticoagulant tube (REF# 683050202, Improve Medical, Guangzhou, China) at 4 days after ICH. The white blood cell count was analyzed using an automatic animal blood cell analyzer (BC-2800 Vet, Mindray Animal Medical, Shenzhen, China).</p>
</sec>
<sec id="s2_12">
<title>Enzyme-linked immunosorbent assay</title>
<p>5 mL of abdominal aortic blood was collected into 5 mL Gel &amp; Clot Activator Tubes (REF# 623050202, Improve Medical, Guangzhou, China) at 7 days after ICH from the rats in Experiment 2 or at 4 days after ICH from the rats in Experiment 3. The concentrations of S100&#x3b2;, TNF-&#x3b1;, IL-1&#x3b2; and IL-6 in the serum were determined using a S100&#x3b2; SimpleStep ELISA<sup>&#xae;</sup> Kit (ab234573, Abcam, Cambridge, United Kingdom), a rat TNF-&#x3b1; ELISA Kit (EK0526, BOSTER, Wuhan, China), a rat IL-1&#x3b2; ELISA Kit (SEKR-0002, Solarbio, Beijing, China) and a rat IL-6 ELISA Kit (CSB-E04640r, CUSABIO, Wuhan, China), respectively, according to the manufacturers&#x2019; instructions. The absorbance value at 450 nm was measured using a microplate reader (Multiskan FC, Thermo Fisher Scientific, USA).</p>
</sec>
<sec id="s2_13">
<title>Measurement of leukocyte counts and MPO activity in BALF</title>
<p>After right main bronchus ligation, BALF was collected from the left lungs of the rats in Experiment 2 at 7 days after ICH or of the rats in Experiment 3 at 4 days after ICH using three consecutive instillations of 1 mL of precooled 0.9% saline. Total and differential leukocyte counts in the BALF collected from the rats in Experiment 3 were analyzed using an automatic animal blood cell analyzer (BC-2800 Vet, Mindray Animal Medical, Shenzhen, China). The BALF from the rats in Experiment 2 was stored at &#x2212;80&#xb0;C. After centrifugation at 1,500 &#xd7; g for 5 min at 4&#xb0;C, MPO activity in the undiluted cell-free BALF was assessed using a MPO activity assay kit (BB-47262, BestBio, Shanghai, China) according to the manufacturer&#x2019;s instructions. The absorbance value at 460 nm was measured using a microplate reader (Multiskan FC, Thermo Fisher Scientific, USA). The results are presented as MPO units per liter of BALF (U/L).</p>
</sec>
<sec id="s2_14">
<title>DNA extraction and 16S rRNA sequencing</title>
<p>Total genomic DNA was extracted from the fecal samples using the E.Z.N.A.<sup>&#xae;</sup> soil DNA kit (Omega Biotek, USA). The quality of the samples was monitored on 1% agarose gels, and the purity and concentration were measured using a NanoDrop 2000 UV&#x2013;Vis spectrophotometer (Thermo Scientific, USA). The DNA was diluted to 1 ng/&#xb5;l, and the V3&#x2013;V4 regions of the bacterial 16S rRNA gene were amplified using the barcoded primers 338 F (5&#x2019;-ACTCCTACGGGAGGCAGCAG-3&#x2019;) and 806 R (5&#x2019;-GGACTACHVGGGTWTCTAAT-3&#x2019;) with an ABI GeneAmp<sup>&#xae;</sup> 9700 PCR thermocycler (ABI, CA, USA). After extraction from the 2% agarose gel, the PCR products were purified using an AxyPrep DNA gel extraction kit (Axygen Biosciences, USA) and quantified using a QuantiFluor&#x2122;-ST fluorometer (Promega, USA). The amplicons were mixed in equimolar concentrations and used for library construction with the TruSeq&#x2122; DNA Sample Prep Kit (Illumina, USA) according to the manufacturer&#x2019;s instructions. Paired-end sequencing was then performed on the Illumina MiSeq PE300 platform/NovaSeq PE250 platform (Illumina, USA) according to the standard protocol of Majorbio Bio-Pharm Technology Co. Ltd. (Shanghai, China). The raw sequencing data were screened, quality-filtered using fastp version 0.19.6 (<ext-link ext-link-type="uri" xlink:href="https://github.com/OpenGene/fastp">https://github.com/OpenGene/fastp</ext-link>) and assembled using FLASH version 1.2.11 (<ext-link ext-link-type="uri" xlink:href="https://ccb.jhu.edu/software/FLASH/index.shtml">https://ccb.jhu.edu/software/FLASH/index.shtml</ext-link>). Operational taxonomic units (OTUs) with 97% similarity were clustered in UPARSE version 11 (<ext-link ext-link-type="uri" xlink:href="http://www.drive5.com/uparse/">http://www.drive5.com/uparse/</ext-link>), with chimeric sequences excluded. The representative sequences were classified into organisms via a na&#xef;ve Bayesian model using the Ribosomal database project classifier version 2.13 (<ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/rdp-classifier/">https://sourceforge.net/projects/rdp-classifier/</ext-link>) against the 16S rRNA database Silva version 138 (<ext-link ext-link-type="uri" xlink:href="https://www.arb-silva.de/">https://www.arb-silva.de/</ext-link>). The analysis of the significant differences in the gut microbial community composition among the groups was further performed using the free online tools of the Majorbio cloud platform (<ext-link ext-link-type="uri" xlink:href="http://www.majorbio.com">www.majorbio.com</ext-link>, Majorbio Biopharm Technology Co., Ltd.).</p>
</sec>
<sec id="s2_15">
<title>Metabolomic analysis of fecal samples</title>
<p>An untargeted metabolomics approach was employed. Briefly, 50 mg fecal sample was added to a 2 mL centrifuge tube containing 400 &#x3bc;L of extraction solution (methanol/water, 4:1, v/v), 0.02 mg/mL the L-2-chlorophenylalanine internal standard and a 6 mm diameter grinding bead. The samples were ground for 6 min at -10&#xb0;C and 50 Hz using a Wonbio-96c frozen tissue grinder (Shanghai Wanbo Biotechnology Co., Ltd., China), followed by low-temperature ultrasonic extraction for 30 min (5&#xb0;C, 40 kHz). The samples were incubated at -20&#xb0;C for 30 min and centrifuged for 15 min (4&#xb0;C, 13000 &#xd7; g), after which the supernatant was transferred to an injection vial for liquid chromatography (LC)&#x2013;mass spectrometry (MS)/MS analysis using a Thermo UHPLC-Q Exactive HF-X system according to the standard protocol of Majorbio Bio-Pharm Technology Co. Ltd. (Shanghai, China). A pooled quality control sample (QC) was prepared by mixing equal volumes of all samples to monitor the stability of the analysis. Chromatography was performed on an ACQUITY HSS T3 column (Waters, USA) with mobile phases consisting of 0.1% formic acid in water/acetonitrile (95:5, v/v, solvent A) and 0.1% formic acid in acetonitrile/isopropanol/water (47.5:47.5:5, v/v, solvent B). The flow rate was 0.40 mL/min, and the column temperature was 40&#xb0;C. The MS analysis was conducted using a Thermo UHPLC-Q Exactive HF-X mass spectrometer equipped with an electrospray ionization (ESI) source operating in positive and negative modes. The optimal conditions used were as follows: source temperature of 425&#xb0;C; ion-spray voltage floating (ISVF) of -3500 V or 3500 V in negative or positive mode, respectively; sheath gas flow rate of 50 arb; aux gas flow rate of 13 arb; normalized collision energy of 20, 40, and 60V rolling for MS/MS. The full MS resolution was 60000, and the MS/MS resolution was 7500. Data acquisition was performed in data-dependent acquisition (DDA) mode. The mass scan range was 70&#x2013;1050 m/z. The raw files obtained were imported into Progensis QI (Waters Corporation, USA) software for data processing. The metabolites were identified by searching the HMDB (<ext-link ext-link-type="uri" xlink:href="http://www.hmdb.ca/">http://www.hmdb.ca/</ext-link>), Metlin (<ext-link ext-link-type="uri" xlink:href="https://metlin.scripps.edu/">https://metlin.scripps.edu/</ext-link>) and Majorbio databases. The data matrix obtained was uploaded to the Majorbio cloud platform (<ext-link ext-link-type="uri" xlink:href="https://majorbio.com">https://majorbio.com</ext-link>) for data analysis. First, the data matrix was preprocessed as follows: At least 80% of the metabolic features detected in any set of samples were retained. After filtering, for specific samples whose metabolite levels were below the lower limit of quantification, the minimum metabolite value was estimated, and each metabolic signature was normalized to the sum. The response intensities of the sample MS peaks were normalized using the sum normalization method to obtain the normalized data matrix and to reduce the errors caused by sample preparation and instrument instability. The variables of the QC samples with a relative standard deviation (RSD) &gt; 30% were excluded, and log10 transformation was performed to obtain the final data matrix for subsequent analysis. The R package ropls version 1.6.2 was subsequently used to perform principal component analysis (PCA) and orthogonal least partial squares discriminant analysis (OPLS-DA), with 7-cycle interactive validation conducted to evaluate the stability of the model. Metabolites with VIP&gt;1 and p&lt;0.05 were determined to be significantly different metabolites based on the variable importance in the projection (VIP) values obtained from the OPLS-DA model and the p values generated by Student&#x2019;s t test. Differentially abundant metabolites were mapped to their biochemical pathways through pathway topology analyses using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (<ext-link ext-link-type="uri" xlink:href="http://www.genome.jp/keg/">http://www.genome.jp/keg/</ext-link>) to obtain additional insights into the underlying biological mechanisms associated with SAP. The identified differential pathways between two groups are presented according to pathway impact values from the pathway topology analysis, with the most impacted pathways marked in red, while the P value represents the enrichment of certain metabolites in a pathway (P&lt;0.05 is indicative of significant enrichment). The Python package scipy version 1.0.0 (<ext-link ext-link-type="uri" xlink:href="https://docs.scipy.org/doc/scipy/">https://docs.scipy.org/doc/scipy/</ext-link>) was used to perform enrichment analyses to obtain the most relevant biological pathways of SAP. Spearman&#x2019;s correlation analyses were performed to explore the associations between differentially abundant genera and metabolites.</p>
</sec>
<sec id="s2_16">
<title>Statistical analysis</title>
<p>All omics data were analyzed using the free online tools of the Majorbio cloud platform (<ext-link ext-link-type="uri" xlink:href="http://www.majorbio.com">www.majorbio.com</ext-link>, Majorbio Biopharm Technology Co., Ltd.). For the analysis of nonomics data, GraphPad software version 9.5.1 (GraphPad, San Diego, CA, USA) was used. The data are presented as the means &#xb1; SEMs. The statistical significance of differences between two groups was determined using two-tailed unpaired Student&#x2019;s t tests. For comparisons of three or more groups, when the data both satisfied a normal distribution and homogeneity of variance, one-way analysis of variance (ANOVA) followed by Tukey&#x2019;s or Bonferroni&#x2019;s multiple comparison test were conducted. When the data were normally distributed but not homogeneous, the Brown&#x2013;Forsythe test and Welch ANOVA test followed by Dunnett&#x2019;s T3 multiple comparison test were used. When the data did not satisfy a normal distribution and homogeneity of variance, the Kruskal&#x2212;Wallis H test followed by Dunnett&#x2019;s T3 multiple comparison test were conducted. Two-way ANOVA followed by Bonferroni&#x2019;s multiple comparisons test were used to evaluate the entire time course variation. For the survival rate analysis, Kaplan&#x2013;Meier analysis with the log-rank test was used. P &lt; 0.05 was considered to indicate statistical significance.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Not all SD rats develop spontaneous pneumonia after ICH, and the severity of spontaneous pneumonia varies even within a group</title>
<p>We established collagenase-induced ICH models by injecting different doses of type VII collagenase into the right caudate nucleus according to the protocol of Rosenberg et&#xa0;al. (<xref ref-type="bibr" rid="B23">23</xref>) to investigate whether SD rats can spontaneously develop pneumonia after ICH. Brain and lung samples were collected 7 days after ICH induction, and histopathological changes were assessed via H&amp;E staining (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1A, B</bold>
</xref>). As expected, the extent of the brain lesions differed substantially among the 3 models and depended on the amount of enzyme injected, since the injection of 0.7 U collagenase caused a larger focal area of damage, whereas the injections of 0.35 U and 0.175 U collagenase induced much smaller or even no apparent damage (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1A</bold>
</xref>). Lung histological changes were also evaluated. As shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1B</bold>
</xref>, significant lung histological deterioration, such as alveolar wall thickening, edema and hemorrhage, was observed in some but not all of the rats in the 3 aforementioned models. Furthermore, the severity of spontaneous pneumonia varies even within a group. Hence, a stable and reproducible bacterial pneumonia model post-ICH is desirable to investigate the pathogenesis of and novel treatments for SAP.</p>
</sec>
<sec id="s3_2">
<title>Establishment of a model of Gram-negative bacterial pneumonia complicating ICH via nasal inoculation with <italic>Kp</italic> after ICH</title>
<p>We established a rat Gram-negative bacterial pneumonia complicating ICH model via nasal inoculation with 2&#xd7;10<sup>5</sup> CFUs of <italic>Kp</italic> 3 days after ICH. The survival rate was 42.9% 7 days after ICH induction (4 days post-<italic>Kp</italic> inoculation, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). mNSS assessments were performed from Day 3 (the day of <italic>Kp</italic> inoculation) to Day 7 after ICH to evaluate ICH-induced neurological impairment. Compared with the sham-operated controls, both the ICH and SAP groups presented higher mNSSs. Moreover, compared with the ICH group, the SAP group presented higher mNSSs at Day 3 after ICH, which indicates more severe neurological deficits (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). Serum S100&#x3b2; is produced mainly by leakage from activated and disrupted astrocytes in the central nervous system (CNS) into the peripheral blood stream in the case of blood&#x2013;brain barrier (BBB) disruption. Elevated peripheral S100&#x3b2; levels have been detected in both ICH patients (<xref ref-type="bibr" rid="B27">27</xref>) and experimental animals (<xref ref-type="bibr" rid="B28">28</xref>) and are often considered a biomarker of brain damage after ICH. We found that the serum S100&#x3b2; level was significantly elevated in both the ICH and SAP groups compared with the sham-operated control group, while a significant difference was not observed between the ICH and SAP groups (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>), indicating that SAP indeed induced brain damage and BBB disruption at Day 7 after ICH. Histological changes in the brain were also evaluated. As shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>, ICH induced significant histological deterioration, and the lesions included a large mosaic-like central zone with pale staining, where extravasated erythrocytes were separated by fragments of necrotic parenchyma, and a perihematomal area, which was a narrow band of poorly stained parenchyma containing either viable or necrotic glial and neuronal cells, with intense infiltration of inflammatory cells. Compared with the ICH group, the SAP group exhibited more severe histological deterioration characterized by more intense infiltration of inflammatory cells not only in the perihematomal area but also in the central zone. Taken together, these data reveal that SAP can induce more serious neurological deficits, brain damage and neuroinflammation in lesions.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Changes in survival rates, mNSS, the serum S100&#x3b2; concentration, the histopathology of brain and lung tissues, and the expression and activity of MPO in the lungs in <italic>Kp</italic>-induced Gram-negative bacterial pneumonia-complicating ICH (SAP) rats. <bold>(A)</bold> Survival rates of sham-operated control, ICH and SAP rats. n = 9&#x2013;14 rats per group. <bold>(B)</bold> Changes in the mNSSs of sham-operated control, ICH and SAP rats. Data were recorded from Day 3 to Day 7 after ICH. n = 6&#x2013;9 rats per group. <bold>(C)</bold> ELISA of S100&#x3b2; levels in the serum of sham-operated control, ICH and SAP rats 7 days after ICH induction. n = 6&#x2013;8 rats per group. <bold>(D, E)</bold> Representative images of H&amp;E-stained brain <bold>(D)</bold> and lung <bold>(E)</bold> sections from sham-operated control, ICH and SAP rats at 7 days after ICH. n = 6&#x2013;7 rats per group. Scale bars, 500 &#x3bc;m <bold>(D)</bold> and 200 &#x3bc;m <bold>(E, F)</bold> Immunofluorescence staining showing MPO-positive cells in the lungs of sham-operated control, ICH and SAP rats at 7 days after ICH. n = 3 rats per group. Scale bars, 200 &#x3bc;m. <bold>(G)</bold> The relative mean fluorescence intensity of MPO. <bold>(H)</bold> MPO activity in the BALF of sham-operated control, ICH and SAP rats at 7 days after ICH. n = 5&#x2013;9 rats per group. The data are presented as the means &#xb1; SEMs. For <bold>(A)</bold>, Kaplan&#x2013;Meier analysis with the log-rank test was used. *P&lt;0.05 for SAP vs. ICH. For <bold>(B)</bold>, two-way ANOVA with Bonferroni&#x2019;s multiple comparisons test was used. *P&lt;0.05, ***P&lt;0.001, and ****P&lt;0.0001 SAP vs. sham-operated control; <sup>&amp;&amp;&amp;&amp;</sup>P&lt;0.0001 ICH vs. sham-operated control; <sup>##</sup>P&lt;0.01 SAP vs. ICH. For <bold>(C)</bold>, one-way ANOVA with Bonferroni&#x2019;s multiple comparisons test was used, *P&lt;0.05. For <bold>(G)</bold>, one-way ANOVA with Turkey&#x2019;s multiple comparisons test was used, **P&lt;0.01. For <bold>(H)</bold>, the Brown&#x2013;Forsythe test and Welch&#x2019;s ANOVA followed by Dunnett&#x2019;s T3 multiple comparison test was used. *P &lt; 0.05 and **P &lt; 0.01. Sham, sham-operated control; ICH, collagenase-induced intracerebral hemorrhage model; SAP, <italic>Kp</italic>-induced Gram-negative bacterial pneumonia complicating ICH model.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1477902-g001.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>
<italic>Kp</italic> challenge exacerbates pulmonary inflammation and lung injury in ICH rats</title>
<p>We evaluated histopathological changes to investigate whether <italic>Kp</italic> challenge could induce pneumonia and lung injury in ICH rats (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>). Lung sections from the sham-operated control group were morphologically normal, whereas those from the ICH group presented focal mild peribronchiolar edema and inflammation. However, SAP rats developed more severe peribronchiolar edema and intense infiltration of inflammatory cells. The rapid influx of neutrophils into the interstitium and bronchoalveolar spaces and subsequent overactivation play key roles in the development and progression of ALI (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). MPO, a member of the heme peroxidase enzyme family, is predominantly secreted by activated neutrophils (<xref ref-type="bibr" rid="B31">31</xref>), the MPO activity can be used as a marker of neutrophil activation (<xref ref-type="bibr" rid="B32">32</xref>). Thus, we performed immunofluorescence staining to analyze the expression of MPO in the lungs of the three groups. As shown in <xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1F, G</bold>
</xref>, both ICH and SAP groups displayed significantly higher levels of MPO than that in the sham-operated control group. The MPO activity in the BALF was also examined. The result revealed that the MPO activity in the BALF of the ICH and SAP groups was significantly higher than that in the sham-operated control group. Moreover, although a significant difference was not observed in pairwise comparisons, the SAP group displayed higher MPO activity than that in the ICH group (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1H</bold>
</xref>). These data indicate that <italic>Kp</italic> challenge aggravates pneumonia and lung injury in ICH rats.</p>
</sec>
<sec id="s3_4">
<title>Disruptions of the intestinal structure and gut barrier and the reductions of the protective intestinal IL-17A-producing &#x3b3;&#x3b4;T cells were observed in <italic>Kp</italic>-induced SAP rats</title>
<p>A growing body of evidence suggests that both ischemic stroke and hemorrhagic stroke can rapidly induce gastrointestinal dysfunction, intestinal structure and gut barrier destructions (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B33">33</xref>). The intestinal histopathological changes were also evaluated. As shown in <xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>, ICH alone did not induce the significant histological deterioration of ileum or colon tissues, probably due to a self-recovery mechanism at 7 days after ICH. However, SAP rats indeed developed obvious histological changes characterized by a thinner layer of epithelium and muscularis mucosae, thickened and shortened villi, a loss of crypts and glands, edema of the lamina propria and intense infiltration of inflammatory cells in the submucosa and muscular layer. The intestinal barrier consists of the intestinal mucus barrier, epithelial barrier and vascular barrier. Among the three layers, the mucus barrier is the first line of defense against harmful organisms, with mucins being the major component of mucus that are secreted mainly by goblet cells. The epithelial barrier is a monolayer cellular barrier tightly bound together by intercellular junctional complexes, including ZOs, occludins, claudins and others (<xref ref-type="bibr" rid="B34">34</xref>). We performed AB-NFR staining and immunofluorescence staining to evaluate the expression of mucins and the tight junction protein ZO-1, respectively, and to analyze changes in the intestinal barrier of the ileum. As expected, the expressions of mucins (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2C&#x2013;E</bold>
</xref>) and ZO-1 (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2F, G</bold>
</xref>) were significantly decreased in both the ICH and SAP groups compared with the sham-operated control group, indicating the damages of the intestinal mucus and epithelial barrier. Studies have shown that &#x3b3;&#x3b4;T cells in the colon mucosa are the primary producers of early protective interleukin (IL)-17A, which can protect mice from dextran sulfate sodium (DSS)-induced gut injury and leakiness by regulating the cellular localization of the tight junction protein occludin (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). IL-17A has also been reported to increase the expression of claudins in intestinal epithelial cells (<xref ref-type="bibr" rid="B37">37</xref>). Thus, both IL-17A and IL-17A-producing &#x3b3;&#x3b4;T cells play important protective roles in maintaining epithelial barriers. Therefore, we also evaluated the expressions of &#x3b3;&#x3b4; TCRs and IL-17A in ileum tissues. As shown in <xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2H-J</bold>
</xref>, the majority of IL-17A-producing cells were &#x3b3;&#x3b4; TCRs-expressing small intestinal intraepithelial &#x3b3;&#x3b4;T lymphocytes, since the IL-17A proteins colocalized with &#x3b3;&#x3b4; TCRs and resided mainly in the paracellular spaces between intestinal epithelial cells. Moreover, the expressions of both &#x3b3;&#x3b4; TCRs and IL-17A were lower in the ICH and SAP group than those in the sham-operated control group. These data indicate that the SAP rats exhibited the intestinal structure and gut barrier damages and the reductions of the protective intestinal IL-17A-producing &#x3b3;&#x3b4;T cells at 7 days after ICH.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>
<italic>Kp</italic>-induced SAP rats exhibited the intestinal structure and gut barrier damages and the reductions of the protective intestinal IL-17A-producing &#x3b3;&#x3b4;T cells at 7 days after ICH induction. <bold>(A, B)</bold> Representative images of H&amp;E staining of ileum <bold>(A)</bold> and colon sections <bold>(B)</bold> from sham-operated control, ICH and SAP rats. n = 4&#x2013;7 rats per group. Scale bars, 100 &#x3bc;m <bold>(A)</bold> and 200 &#x3bc;m <bold>(B&#x2013;D)</bold> AB&#x2013;NFR staining of acidic mucins in the ileums of sham-operated control, ICH and SAP rats. n = 3 rats per group. Scale bars, 500 &#x3bc;m <bold>(C)</bold> and 100 &#x3bc;m <bold>(D, E)</bold> Proportion of positive area of AB-PAS staining of ileum tissues. <bold>(F)</bold> Immunofluorescence staining for ZO-1 in the ileums of sham-operated control, ICH and SAP rats. n = 3&#x2013;5 rats per group. Scale bars, 100 &#x3bc;m. <bold>(G)</bold> The relative mean fluorescence intensity of ZO-1. <bold>(H)</bold> Immunofluorescence staining showing &#x3b3;&#x3b4; TCR- and IL-17A-positive cells in the ileums of sham-operated control, ICH and SAP rats. n = 3 rats per group. Scale bars, 100 &#x3bc;m. <bold>(I, J)</bold> The relative mean fluorescence intensity of &#x3b3;&#x3b4; TCR <bold>(I)</bold> or IL-17A <bold>(J)</bold>. The data are presented as the means &#xb1; SEMs. For <bold>(E, I, J)</bold>, one-way ANOVA and Turkey&#x2019;s multiple comparisons test were used. For <bold>(G)</bold>, one-way ANOVA and Bonferroni&#x2019;s multiple comparisons test were used. *P &lt; 0.05, **P &lt; 0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1477902-g002.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>
<italic>Kp</italic> challenge exacerbates gut microbiota dysbiosis in ICH rats</title>
<p>A profound alteration in the gut microbiota composition occurred in <italic>Kp</italic>-challenged mice (<xref ref-type="bibr" rid="B38">38</xref>), which was also observed in stroke and SAP patients and corresponding experimental animal models (<xref ref-type="bibr" rid="B39">39</xref>&#x2013;<xref ref-type="bibr" rid="B43">43</xref>). Therefore, we performed 16S rRNA sequencing to explore the changes in the gut microbiota in <italic>Kp</italic>-induced SAP rats. The data revealed no significant differences in alpha diversity indices among the sham-operated control, ICH and SAP groups (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2A-F</bold>
</xref>). We further used the Gut Microbiome Health Index (GMHI) (<xref ref-type="bibr" rid="B44">44</xref>) or the Microbial Dysbiosis Index (MDI) (<xref ref-type="bibr" rid="B45">45</xref>) to predict the health status or the severity of dysbiosis via OTU-level gut microbiome profiling. The data revealed that the GMHI index of the ICH group was significantly lower than that of the sham-operated control group, while that of the SAP group was further lower (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>), indicating that the intestinal health of the SAP rats further deteriorated. In contrast, the MDI index of the ICH group was significantly higher relative to the sham-operated control group, while that of the SAP group was further higher (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>), suggesting that the dysbiosis of gut microbiota was further aggravated. Based on the Bray&#x2013;Curtis distances, principal coordinate analysis (PCoA) also revealed that the gut microbial community structure of the SAP group was clearly separated from those of the sham-operated control and ICH groups (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). Next, we analyzed alterations in microbial compositions and abundances of specific bacteria at different taxonomic levels. At the phylum level, the relative abundance of <italic>Firmicutes</italic> was significantly decreased in the SAP group compared with the sham-operated control, whereas that of <italic>Actinobacteria</italic> was significantly increased in the SAP group compared to both the sham-operated control and ICH groups. The relative abundance of <italic>Patescibacteria</italic> was significantly different among the three groups and tended to increase in the SAP group but did not differ significantly in pairwise comparisons (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>,  <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2H-J</bold>
</xref>). At the genus level, 37 genera differed among the three groups. Among the top 15 differential genera, <italic>Blautia</italic> was decreased in the SAP group compared with the ICH group. <italic>Norank_f:Ruminococcaceae</italic> was decreased in the SAP group compared with sham-operated controls. <italic>Allobaculum</italic> and <italic>Faecalitalea</italic> were depleted in the SAP group. In contrast, <italic>Romboutsia</italic>, <italic>Clostridium_sensu_stricto_1</italic>, <italic>Bifidobacterium</italic>, <italic>Corynebacterium</italic>, and <italic>Enterorhabdus</italic> were increased in the SAP group compared with both the sham-operated control and ICH groups. <italic>Turicibacter</italic> was significantly increased in the SAP group compared to the ICH group. <italic>Lachnospiraceae_NK4A136_group</italic>, <italic>Staphylococcus</italic>, <italic>Roseburia</italic>, <italic>Tyzzerella</italic> and <italic>norank_f:Lachnospiraceae</italic> were significantly different among the three groups and tended to increase in the SAP group but did not differ significantly in pairwise comparisons (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3G</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2K</bold>
</xref>). We further employed linear discriminant analysis (LDA) effect size (LEfSe) analysis to identify the specific bacterial taxa that differed among the three groups. In total, 31 differentially abundant bacterial taxa were identified when the LDA score was &gt;3.5 and are displayed in a cladogram (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3H</bold>
</xref>). Among them, <italic>Lactobacillales</italic>, <italic>Erysipelotrichaceae</italic>, <italic>Allobaculum</italic>, <italic>Paludicola</italic>, and <italic>Faecalitalea</italic> were the dominant bacteria in the sham-operated control group; <italic>Blautia</italic>, <italic>Anaerofilum</italic>, <italic>GCA-900066755</italic>, <italic>Staphylococcales</italic>, <italic>Staphylococcaceae</italic>, <italic>Staphylococcus</italic>, and <italic>Yaniella</italic> were the most abundant bacteria in the ICH group; and <italic>Actinobacteriota</italic>, <italic>Actinobacteria</italic>, <italic>Romboutsia</italic>, <italic>Peptostreptococcaceae</italic>, <italic>Peptostreptococcales-Tissierellales</italic>, <italic>Clostridium_sensu_stricto_1</italic>, <italic>Clostridiaceae</italic>, <italic>Clostridiales</italic>, <italic>Bifidobacteriaceae</italic>, <italic>Bifidobacterium</italic>, <italic>Bifidobacteriales</italic>, <italic>Turicibacter</italic>, <italic>Lachnospiraceae_NK4A136_group</italic>, <italic>Corynebacteriales</italic>, <italic>Corynebacteriaceae</italic>, <italic>Corynebacterium</italic>, <italic>Enterorhabdus</italic>, <italic>norank_f:Lachnospiraceae</italic> and <italic>UCG-004</italic> were the dominant bacteria in the SAP group (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3I</bold>
</xref>). Taken together, these data indicate that <italic>Kp</italic> challenge exacerbates gut microbiota dysbiosis in ICH rats.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>
<italic>Kp</italic> challenge exacerbated gut microbiota dysbiosis 7 days after ICH induction. <bold>(A, B)</bold> Comparisons of the GMHI between the ICH and sham-operated control groups <bold>(A)</bold> or between the ICH and SAP groups <bold>(B&#x2013;D)</bold> Comparisons of the MDI between the ICH and sham-operated control groups <bold>(C)</bold> or between the ICH and SAP groups <bold>(D, E)</bold> PCoA of the microbial communities based on the Bray&#x2013;Curtis distance at the OTU level. <bold>(F, G)</bold> Relative abundances of bacterial taxa at the phylum <bold>(F)</bold> or genus <bold>(G)</bold> level. Only phyla or genera with an average relative abundance &gt; 1% are shown. <bold>(H)</bold> Cladograms generated by LEfSe indicating differences in the bacterial taxa among the three groups. The color nodes indicate the groups. Red, blue, and green nodes, differential taxa enriched in the sham-operated control, ICH, and SAP groups, respectively. Yellow nodes, taxa with no significant differences among the three groups. <bold>(I)</bold> LEfSe analysis was used to identify the differential bacterial taxa among the three groups. n = 6 rats per group. <bold>(A-D)</bold> Two-tailed Wilcoxon rank-sum test. *P &lt; 0.05 and **P &lt; 0.01. For <bold>(H, I)</bold>, the Kruskal&#x2212;Wallis H test was used. Only taxa with P values &lt;0.05 and LDA scores greater than 3.5 are shown.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1477902-g003.tif"/>
</fig>
</sec>
<sec id="s3_6">
<title>
<italic>Kp</italic> challenge causes profound alterations in the fecal metabolome in ICH rats</title>
<p>
<italic>Kp</italic> infection led to a profound change in the cecal metabolic profile (<xref ref-type="bibr" rid="B38">38</xref>). Both stroke and SAP also induce metabolic alterations (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>). Hence, we adopted an LC&#x2212;MS/MS-based untargeted metabolomic method to profile changes in the fecal metabolome of SAP rats. We first used unsupervised PCA to evaluate the overall metabolome differences among the three groups and the degree of variability across samples within groups. The data revealed that the metabolic profile of the SAP group was clearly separated from that of the sham-operated control group, whereas the metabolic profile of the ICH group appeared approximately midway between that of the sham-operated control group and the SAP group, and the overall metabolic profile remained more similar to that of the sham-operated control group (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). We distinguished metabolic differences between groups more precisely and screened the variables that contributed to the separation of each group by employing orthogonal partial least squares discriminant analysis (OPLS-DA). As illustrated in <xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4B-D</bold>
</xref>, the three groups could be clearly separated from each other, indicating that their metabolic profiles were distinct. Differentially abundant metabolites with OPLS-DA VIP&gt;1 and p &lt; 0.05 were subsequently screened between groups and presented in a volcano plot (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4E&#x2013;G</bold>
</xref>). In total, 416 differentially abundant metabolites were identified between the ICH group and the sham-operated control group, with 129 upregulated and 287 downregulated in the ICH group (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>). In addition, 1000 differentially abundant metabolites were found between the SAP group and sham-operated controls, of which 577 were upregulated and 423 were downregulated in SAP rats (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>). Furthermore, compared to those in ICH rats, 755 differentially abundant metabolites were detected in SAP rats, of which 511 were upregulated and 244 were downregulated (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4G</bold>
</xref>). We performed KEGG topology analysis to characterize the differentially abundant metabolites in the context of biological pathways and identified tryptophan (Trp) metabolism as one of the top three significantly different metabolic pathways between the sham-operated control and ICH groups (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4H</bold>
</xref>). We also identified sphingolipid metabolism as the most significantly different metabolic pathway between the sham-operated control and SAP groups or between the ICH and SAP groups (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4I, J</bold>
</xref>), suggesting that ICH dramatically affected Trp metabolism, whereas <italic>Kp</italic> challenge dramatically affected sphingolipid metabolism.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>
<italic>Kp</italic> challenge caused profound alterations in the fecal metabolic profile 7 days after ICH induction. <bold>(A)</bold> PCA score plot of the overall fecal metabolic profile differences among the sham-operated control, ICH and SAP groups. <bold>(B-D)</bold> OPLS-DA score plots of the sham-operated control vs. ICH <bold>(B)</bold>, sham-operated control vs. SAP <bold>(C)</bold>, and ICH vs. SAP groups <bold>(D)</bold>. The validation plots were obtained from 200 tests. <bold>(E-G)</bold> Volcano plots of the significantly differentially abundant metabolites for the sham-operated control vs. ICH <bold>(E)</bold>, sham-operated control vs. SAP <bold>(F)</bold>, and ICH vs. SAP <bold>(G)</bold> groups screened in positive and negative ion modes. <bold>(H-J)</bold> KEGG topology analyses of the differentially abundant metabolic pathways identified from the comparisons of the sham-operated control vs. ICH <bold>(H)</bold>, sham-operated control vs. SAP <bold>(I)</bold>, and ICH vs. SAP groups <bold>(J)</bold>. Only the top five differentially abundant metabolic pathways are marked according to the impact value. n = 6 rats per group. For <bold>(E-G)</bold>, two-tailed unpaired Student&#x2019;s t test was used, and P &lt; 0.05 was considered to indicate statistical significance. For <bold>(H-J)</bold>, relative-betweenness centrality was adopted for topology analyses. The Benjamini&#x2013;Hochberg multiple correction method was used to verify the P values and control the false-positives of the topology results. A corrected P &lt; 0.05 was considered to indicate statistical significance.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1477902-g004.tif"/>
</fig>
</sec>
<sec id="s3_7">
<title>
<italic>Kp</italic> challenge leads to abnormal sphingolipid metabolism and elevated ceramide levels in ICH rats</title>
<p>Since the analysis of the global fecal metabolic profile revealed that the most prominent altered metabolic pathway in SAP rats was sphingolipid metabolism, we further explored the differentially abundant sphingolipid metabolites. The data revealed that some long-chain ceramides, such as Cer (d18:0/14:0) and Cer (d18:1/17:0), were more abundant in the SAP group than those in the sham-operated control and ICH groups (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5B, C</bold>
</xref>), whereas the Cer (d18:0/16:0) level was significantly increased in the SAP group compared with the sham-operated control group (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>). However, that of the glycosylated ceramide derivative galactosylceramide (d18:1/14:0) was significantly decreased in the SAP group compared with both the sham-operated control and ICH groups (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref>), whereas that of Cer (d20:1/18:3 (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B15">15</xref>)-OH (<xref ref-type="bibr" rid="B9">9</xref>)) was significantly decreased compared to the sham-operated control group (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5F</bold>
</xref>). Ceramides can be synthesized through the <italic>de novo</italic> pathway (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>), which starts from the condensation of L-serine and palmitoyl coenzyme A (CoA) to produce 3-ketosphinganine, which is subsequently reduced to produce sphinganine (dihydrosphingosine). Then, an acyl-CoA chain is bound to form dihydroceramide, which is ultimately converted into ceramide (<xref ref-type="bibr" rid="B48">48</xref>). We observed a significantly increased level of 3-ketosphinganine in the SAP group compared to both the sham-operated control and ICH groups (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5G</bold>
</xref>); however, although the relative abundance of sphinganine was significantly different among the three groups and tended to be higher in the SAP group than in the ICH group, no significant differences were observed in pairwise comparisons (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5H</bold>
</xref>). Ceramides can also be produced through the sphingomyelin (SM) hydrolysis pathway (<xref ref-type="bibr" rid="B48">48</xref>). We observed a significantly decreased level of SM(d16:1/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH (7S, 17S)) in the SAP group than that in the sham-operated control and ICH groups (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5I</bold>
</xref>). Ceramides can also be hydrolyzed into sphingosines, which can either be phosphorylated to generate the pleiotropic bioactive metabolite sphingosine-1-phosphate or re-utilized in the salvage pathway to generate ceramides (<xref ref-type="bibr" rid="B49">49</xref>). We found that the levels of sphingosine and dehydrophytosphingosine were significantly increased in the SAP group compared with both the sham-operated control and ICH groups (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5J, L</bold>
</xref>), whereas that of galactosylsphingosine was more abundant in the SAP group than that in the ICH group (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5K</bold>
</xref>). Taken together, these data suggested that <italic>Kp</italic> challenge led to abnormal elevated ceramides levels through the activations of the <italic>de novo</italic>, the sphingomyelinase hydrolysis and the salvage pathways of sphingolipid metabolism.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>
<italic>Kp</italic> challenge led to abnormal sphingolipid metabolism and elevated ceramide levels 7 days after ICH induction. <bold>(A)</bold> Schematic depiction of ceramide biosynthesis via the <italic>de novo</italic>, salvage, and sphingomyelin hydrolysis pathways. <bold>(B-L)</bold> Key differentially abundant metabolites involved in the sphingolipid metabolism pathway among the sham-operated control, ICH and SAP groups. The data are presented as the means &#xb1; SDs. n = 6 rats per group. For <bold>(B-L)</bold>, one-way ANOVA and the Tukey&#x2212;Kramer <italic>post hoc</italic> test were used. *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1477902-g005.tif"/>
</fig>
</sec>
<sec id="s3_8">
<title>
<italic>Kp</italic> challenge increases neurotoxic quinolinic acid levels and upregulates the Trp&#x2013;serotonin&#x2013;melatonin pathway in ICH rats</title>
<p>In humans, Trp is an essential amino acid that must be obtained from the diet. In addition to being involved in protein synthesis, Trp can also be degraded through two main pathways (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>): the first is the kynurenine pathway, through which Trp is metabolized into kynurenine, followed by kynurenic acid, anthranilic acid, picolinic acid, QA and other neuroactive intermediates; and the other is the serotonin pathway, through which TRP is metabolized into serotonin and its downstream products, such as melatonin, acetyl-N-formyl-5-methoxykynurenamine, 5-hydroxyindoleacetylglycine and 5-methoxyindoleacetate (<xref ref-type="bibr" rid="B50">50</xref>). Since the analysis of the global fecal metabolic profile revealed that ICH dramatically altered Trp metabolism, we further explored the differentially abundant metabolites in this pathway in SAP rats. The data revealed that the levels of the Trp-kynurenine pathway metabolites N&#x2019;-formylkynurenine and picolinic acid were significantly lower in the ICH group than in the sham-operated control group but were higher in the SAP group (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6B, C</bold>
</xref>). However, the level of neurotoxic QA (<xref ref-type="bibr" rid="B51">51</xref>) was significantly increased in SAP compared to ICH rats (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>), indicating that ICH led to a significant downregulation of the Trp&#x2013;kynurenine pathway, whereas <italic>Kp</italic> challenge induced increased neurotoxic QA production in ICH rats. We also found that the levels of the Trp&#x2013;serotonin&#x2013;melatonin pathway metabolites serotonin and melatonin derivatives 3-hydroxymelatonin, acetyl-N-formyl-5-methoxykynurenamine and 6-hydroxymelatonin were significantly increased in the SAP group compared with both the sham-operated control and ICH groups (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6E&#x2013;H</bold>
</xref>), whereas the levels of the Trp&#x2013;serotonin pathway metabolite 5-hydroxyindoleacetylglycine were significantly decreased in the SAP group compared with both the sham-operated control and ICH groups (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6I</bold>
</xref>), and the level of 5-methoxyindoleacetate was significantly decreased in the ICH group compared with the sham-operated control group but was increased in the SAP group (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6J</bold>
</xref>), indicating that <italic>Kp</italic> challenge induced significant upregulation of the Trp&#x2013;serotonin pathway characterized by increased levels of melatonin derivatives but decreased 5-hydroxyindoleacetylglycine levels. Taken together, these data suggest that <italic>Kp</italic> challenge increases neurotoxic QA levels and upregulates the Trp&#x2013;serotonin&#x2013;melatonin pathway in ICH rats.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>
<italic>Kp</italic> challenge caused increased levels of neurotoxic quinolinic acid and an upregulation of tryptophan (Trp)&#x2013;serotonin&#x2013;melatonin pathway 7 days after ICH induction. <bold>(A)</bold> Schematic depiction of Trp metabolism via the kynurenine and serotonin pathways. <bold>(B-J)</bold> Key differentially abundant metabolites involved in the Trp metabolism pathway among the sham-operated control, ICH and SAP groups. The data are presented as the means &#xb1; SDs. n = 6 rats per group. For <bold>(B-J)</bold>, one-way ANOVA and the Tukey&#x2212;Kramer <italic>post hoc</italic> test were used. *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1477902-g006.tif"/>
</fig>
</sec>
<sec id="s3_9">
<title>Correlations between the differential genera and differentially abundant sphingolipid or Trp metabolites</title>
<p>We summarized the 37 differential genera among the three groups (P &lt; 0.05, LDA &gt; 2) and performed Spearman&#x2019;s correlation analyses to further investigate the mechanistic links between gut dysbiosis and the disturbance of sphingolipid metabolism. As shown in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>, some differential genera enriched in <italic>Kp</italic>-induced SAP rats, such as <italic>Dietzia</italic>, <italic>Bifidobacterium</italic>, <italic>Muribaculum</italic>, <italic>UCG-004</italic>, <italic>Aerococcus</italic>, <italic>Enterorhabdus</italic>, <italic>Bacteroides_pectinophilus_group</italic>, <italic>Turicibacter</italic>, and <italic>Clostridium_sensu_stricto_1</italic>, were positively associated with the differentially abundant sphingolipid metabolites upregulated in SAP rats, including Cer(d18:0/14:0), Cer(d18:1/17:0), Cer(d18:0/16:0), 3-ketosphinganine, sphingosine, galactosylsphingosine and dehydrophytosphingosine. However, the differential genera enriched in sham-operated control rats but decreased or even depleted in SAP rats, such as <italic>Allobaculum</italic>, <italic>Faecalitalea</italic>, <italic>norank_f:Ruminococcaceae</italic>, <italic>Gordonibacter</italic>, <italic>Phascolarctobacterium</italic> and <italic>Paludicola</italic>, were negatively associated with the aforementioned differentially abundant metabolites upregulated in SAP rats. Surprisingly, almost all the genera that positively correlated with the sphingolipid metabolites upregulated in SAP rats were negatively correlated with that downregulated in the SAP group, including galactosylceramide (d18:1/14:0), Cer(d20:1/18:3 (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B15">15</xref>)-OH (<xref ref-type="bibr" rid="B9">9</xref>)), SM(d16:1/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)), and vice versa. We also performed Spearman&#x2019;s correlation analyses to investigate the relationships between the differential genera and the differentially abundant Trp metabolites. As shown in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>, some differential genera enriched in <italic>Kp</italic>-induced SAP rats, such as <italic>Bifidobacterium</italic>, <italic>UCG-004</italic>, <italic>Dietzia</italic>, <italic>Turicibacter</italic>, <italic>Aerococcus</italic>, <italic>Clostridium_sensu_stricto_1</italic>, <italic>Romboutsia</italic>, <italic>Candidatus_Saccharimonas</italic>, <italic>Enterorhabdus</italic>, <italic>Muribaculum</italic>, and <italic>Corynebacterium</italic>, were positively associated with the key differentially abundant Trp metabolites upregulated in SAP rats, including QA, serotonin, acetyl-N-formyl-5-methoxykynurenamine, 3-hydroxymelatonin, and 6-hydroxymelatonin, and other metabolites that were changed in SAP rats, such as N&#x2019;-formylkynurenine and picolinic acid. However, the differential genera enriched in sham-operated control rats but decreased or even depleted in SAP rats, such as <italic>Allobaculum</italic>, <italic>Faecalitalea</italic>, <italic>norank_f:Ruminococcaceae</italic>, <italic>Gordonibacter</italic>, <italic>Phascolarctobacterium</italic> and <italic>Paludicola</italic>, were negatively associated with the aforementioned differentially abundant Trp metabolites that changed in the SAP group. Notably, almost all the genera that positively correlated with the aforementioned differentially abundant metabolites changed in SAP rats were negatively correlated with 5-hydroxyindoleacetylglycine that downregulated in the SAP group, and vice versa. Taken together, these results suggested that the depletion of <italic>Allobaculum</italic> and <italic>Faecalitalea</italic>, the reduction in <italic>norank_f:Ruminococcaceae</italic>, <italic>Gordonibacter</italic>, <italic>Phascolarctobacterium</italic> and <italic>Paludicola</italic>, and the increase in <italic>Bifidobacterium</italic>, <italic>UCG-004</italic>, <italic>Dietzia</italic>, <italic>Turicibacter</italic>, <italic>Romboutsia</italic>, <italic>Candidatus_Saccharimonas</italic>, <italic>Clostridium_sensu_stricto_1</italic>, <italic>Aerococcus</italic>, <italic>Enterorhabdus</italic>, <italic>Muribaculum, Bacteroides_pectinophilus_group</italic>, <italic>Corynebacterium</italic> and other differential genera in SAP rats are associated with the disordered sphingolipid and Trp metabolism.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Correlations between differential genera and differentially abundant sphingolipid or Trp metabolites. <bold>(A, B)</bold> Spearman&#x2019;s correlation analyses between the differential genera and differentially abundant sphingolipid <bold>(A)</bold> or Trp <bold>(B)</bold> metabolites among the sham-operated control, ICH and SAP groups. Each row represents a metabolite, each column represents a genus, and each lattice represents the Spearman correlation coefficient between a genus and a metabolite. Red indicates a positive correlation, whereas blue indicates a negative correlation. Correlations were considered significant when P &lt; 0.05. n = 6 rats per group. *P &lt; 0.05, **P &lt; 0.01, and ***P &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1477902-g007.tif"/>
</fig>
</sec>
<sec id="s3_10">
<title>Establishment of a model of ALI complicating ICH via intratracheal inoculation with LPS after ICH</title>
<p>Due to biosafety concerns, we further established LPS-induced ALI complicating ICH model through intratracheal inoculation of 3 mg/kg LPS after ICH. The survival rate was 73.3% at 4 days after ICH induction (1 day after the LPS inoculation, <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). Significant reductions in body weight were observed on the day of LPS inoculation and at 1 day post-LPS inoculation (at 3 and 4 days after ICH) in the SAP group compared with the sham-operated control group (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3A</bold>
</xref>). A significant increase in the mNSS was also observed beginning on the day of ICH induction (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3B</bold>
</xref>). MRI was also performed to detect the lesion locations and measure the volume of hematoma using SWI pulse sequences. The results showed that the injection of 0.5 U type VII collagenase indeed induced an approximately 0.3 ml hematoma volume within the right caudate nucleus at 4 days after ICH (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B, C</bold>
</xref>). Histopathological changes in the brain were also evaluated. As shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3C</bold>
</xref>, SAP rats displayed significant histopathological deterioration, especially moderate infiltration of inflammatory cells in the perihematomal area. Taken together, these data revealed that significant weight loss, serious neurological deficits, and brain damage with perihematomal inflammatory cell infiltration also occurred in LPS-induced ALI complicating ICH rats.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Changes in survival rates, hematoma volume, and peripheral and pulmonary immune responses in rats with LPS-induced ALI complicating ICH at 4 days after ICH induction. <bold>(A)</bold> Survival rates of SAP and sham-operated control rats. Kaplan&#x2013;Meier analysis with the log-rank test were used. n = 15 rats per group. <bold>(B)</bold> Representative MR images of hematomas in SAP rats. SWI was performed to visualize the hematoma using a 3.0-T MRI scanner. <bold>(C)</bold> Quantification of the hematoma volume in SAP rats, which was calculated using the Coniglobus formula. For <bold>(B, C)</bold>, n = 3 rats per group. <bold>(D-J)</bold> Changes in the number of circulating leukocytes in SAP rats relative to those in sham-operated control rats. <bold>(D)</bold> Total leukocyte count; <bold>(E)</bold> monocyte count; <bold>(F)</bold> proportion of monocytes; <bold>(G)</bold> neutrophil count; <bold>(H)</bold> proportion of neutrophils; <bold>(I)</bold> lymphocyte count; <bold>(J)</bold> proportion of lymphocytes. n = 11&#x2013;15 rats per group. <bold>(K-M)</bold> ELISAs of TNF-&#x3b1; <bold>(K)</bold>, IL-1&#x3b2; <bold>(L)</bold> and IL-6 <bold>(M)</bold> levels in the serum of sham-operated control, 2 mg/kg LPS-induced or 3 mg/kg LPS&#x2212;induced SAP rats. n = 7&#x2013;15 rats per group. <bold>(N-R)</bold> Changes in leukocytes in the BALF of 3 mg/kg LPS&#x2212;induced SAP rats relative to those in the BALF of 2 mg/kg LPS&#x2212;induced SAP rats or sham-operated control rats. <bold>(N)</bold> Total leukocyte count; <bold>(O)</bold> lymphocyte count; <bold>(P)</bold> proportion of lymphocytes; <bold>(Q)</bold> neutrophil count; <bold>(R)</bold> proportion of neutrophils. n = 7&#x2013;15 rats per group. The data are presented as the means &#xb1; SEMs. For <bold>(C-J)</bold>, two-tailed unpaired Student&#x2019;s t test was used; for <bold>(K&#x2212;M)</bold>, the Kruskal&#x2212;Wallis H test and Dunnett&#x2019;s T3 multiple comparison test were used; for <bold>(N, O, Q)</bold>, the Brown&#x2212;Forsythe test, Welch&#x2019;s ANOVA and Dunnett&#x2019;s T3 multiple comparison test were used; for <bold>(P, R)</bold>, one&#x2212;way ANOVA and Tukey&#x2019;s multiple comparison test were used. *P&lt;0.05, **P&lt;0.01, and ****P&lt;0.0001. Sham, sham-operated control; SAP, 3 mg/kg LPS&#x2212;induced ALI complicating ICH model; 2 mg/kg LPS, 2 mg/kg LPS&#x2212;induced ALI complicating ICH model; 3 mg/kg LPS, 3 mg/kg LPS&#x2212;induced ALI complicating ICH model.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1477902-g008.tif"/>
</fig>
</sec>
<sec id="s3_11">
<title>The peripheral immune response is dysregulated in LPS-induced ALI complicating ICH rats</title>
<p>Immunosuppression after stroke is characterized primarily by a rapid and massive loss of T cells due to apoptosis, which is a key pathological event correlated with increased susceptibility to life-threatening infections such as SAP (<xref ref-type="bibr" rid="B9">9</xref>). Moreover, significantly elevated total leukocyte counts, monocyte counts, neutrophil counts and cytokine levels in the blood have been observed in patients with stroke-associated infection compared with those without stroke-associated infection (<xref ref-type="bibr" rid="B52">52</xref>). Therefore, we performed a routine blood test to count and classify leukocytes in the blood. The data revealed no significant differences in total leukocyte or lymphocyte counts between the sham-operated control and SAP groups (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8D, I</bold>
</xref>). In addition, the numbers and proportions of monocytes and neutrophils were significantly increased in the SAP group compared to the sham-operated control group (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8E&#x2013;H</bold>
</xref>). However, the proportion of lymphocytes was significantly decreased in SAP rats compared to sham-operated control rats, suggesting that immunosuppression also occurred in LPS-induced ALI complicating ICH rats (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8J</bold>
</xref>). The upregulation of inflammatory cytokines is an important feature of ALI (<xref ref-type="bibr" rid="B53">53</xref>). Therefore, we performed ELISAs to determine the levels of TNF-&#x3b1;, IL-1&#x3b2; and IL-6 in the serum. The data revealed that TNF&#x2212;&#x3b1; levels were only significantly increased in the 3 mg/kg LPS&#x2212; but not 2 mg/kg LPS&#x2212;induced SAP rats compared with the sham-operated control (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8K</bold>
</xref>). IL-1&#x3b2; levels were significantly increased in both 2 mg/kg LPS- and 3 mg/kg LPS&#x2212;induced SAP rats compared with sham-operated control (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8L</bold>
</xref>). However, no significant differences in the IL-6 levels were observed among the three groups (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8M</bold>
</xref>). Taken together, these data reveal that the peripheral immune response is dysregulated in 3 mg/kg LPS-induced SAP rats, which is characterized by a decreased proportion of lymphocytes, increased numbers and proportions of monocytes and neutrophils, and upregulation of the inflammatory cytokines TNF&#x2212;&#x3b1; and IL-1&#x3b2;.</p>
</sec>
<sec id="s3_12">
<title>An intense pulmonary inflammatory response and histopathological changes occur in LPS-induced ALI complicating ICH rats</title>
<p>An excessive inflammatory response caused by a quick influx of neutrophils into the lung is a hallmark of ALI and plays a key role in the progression of ALI and ARDS (<xref ref-type="bibr" rid="B54">54</xref>). Thus, at 1 day after LPS challenge, the BALF were prepared, and the leukocytes were counted and classified. As shown in <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8N</bold>
</xref>, the total leukocyte count was significantly increased in 3 mg/kg LPS&#x2212;induced SAP rats compared with both the sham-operated control and 2 mg/kg LPS&#x2212;induced SAP rats. The number of lymphocytes was significantly increased only in 3 mg/kg LPS&#x2212;induced SAP rats (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8O</bold>
</xref>). The proportions of lymphocytes and the numbers of neutrophils were significantly increased in both 2 mg/kg LPS- and 3 mg/kg LPS&#x2212;induced SAP rats (<xref ref-type="fig" rid="f8">
<bold>Figures&#xa0;8P, Q</bold>
</xref>), whereas the proportions of neutrophils were significantly decreased in both 2 mg/kg LPS- and 3 mg/kg LPS&#x2212;induced SAP rats (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8R</bold>
</xref>). Pulmonary histopathological changes were also evaluated. As shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3D</bold>
</xref>, 3 mg/kg LPS&#x2212;induced SAP rats presented marked alveolar wall and bronchiolar wall thickening, alveolar and bronchiolar collapse, peribronchiolar and interstitial edema and intense infiltration of inflammatory cells into the lung interstitium and alveolar spaces, whereas the sham-operated control rats presented no obvious histological alterations. Taken together, these data reveal that an intense pulmonary inflammatory response and histopathological changes occur in LPS-induced ALI complicating ICH rats, and 3 mg/kg LPS is more appropriate than 2 mg/kg LPS for establishing an ALI complicating ICH model.</p>
</sec>
<sec id="s3_13">
<title>Disruption of the intestinal structure and histopathological changes in the ileums in LPS-induced ALI complicating ICH rats</title>
<p>We also performed H&amp;E staining to evaluate the histopathological changes in the ileum sections. As shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3E</bold>
</xref>, at 1 day after LPS challenge, SAP rats presented obvious histological changes characterized by thinner layers of epithelium and muscularis mucosae, shortened villi or even a loss of villi, and intense infiltration of inflammatory cells in the submucosa and muscular layer, whereas sham-operated control rats presented no obvious histological alterations.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>In this study, we established a standardized <italic>Kp</italic>-induced Gram-negative bacterial pneumonia complicating ICH model with the following characteristics (1): severe neurological deficits, brain damage, BBB disruption and neuroinflammation in the lesions; (2) lung injury and pneumonia, especially intense infiltration and activation of neutrophils; (3) disruptions of the intestinal structure and gut barrier and downregulations of protective intestinal IL-17A-producing &#x3b3;&#x3b4;T cells; and (4) profound alterations in the fecal microbial community composition and metabolic profile. Due to biosafety concerns, we further established a standardized LPS-induced ALI complicating ICH model that displayed the following characteristics: (1) significant weight loss, severe neurological deficits, brain damage and perihematomal inflammatory cells infiltration; (2) a dysregulated peripheral immune response characterized by a decreased proportion of lymphocytes, increased numbers and proportions of monocytes and neutrophils, and the upregulations of inflammatory cytokines TNF&#x2212;&#x3b1; and IL-1&#x3b2;; (3) lung injury and a robust inflammatory response in BALF characterized by increased numbers of leukocytes and neutrophils, as well as a decreased number and proportion of leukocytes but a decreased proportion of neutrophils; and (4) disruption of the intestinal structure and histopathological changes in the ileum. Taken together, the changes in peripheral and local immune responses in the blood, lung and ileum; alterations in the fecal microbiota and metabolic profile; and histopathological changes in the brain, lung and gut tissues, all the pathological features mentioned above, supporting the successful establishments of these two models since they are able to duplicate at least some of the mechanisms and consequences of human hemorrhagic stroke and SAP.</p>
<p>SAP is one of the major complications after stroke that worsens functional outcomes (<xref ref-type="bibr" rid="B4">4</xref>). However, current prophylactic or therapeutic antibiotic therapies have been proven to be ineffective or need to be used cautiously because of unexpected side effects (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Thus, more effective therapeutic strategies that target the underlying pathogenesis of SAP are urgently needed. Accumulating evidence suggests that complex multidirectional communications exist among stroke, the gut and lung, which involve the gut microbiota, metabolites, nervous system, neuroendocrine system, immune system, etc (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>). The dysbiosis of the gut microbiota is considered closely related to the pathogenesis of lung inflammation (<xref ref-type="bibr" rid="B55">55</xref>), lung infection (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B56">56</xref>), stroke and SAP (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B43">43</xref>), thus, it is considered a promising therapeutic target (<xref ref-type="bibr" rid="B57">57</xref>). In this study, we also observed a profound alteration in the fecal microbiota in rats with <italic>Kp</italic>-induced Gram-negative bacterial pneumonia complicating ICH, which is characterized by the depletion of <italic>Allobaculum</italic>, <italic>Faecalitalea</italic>, the reduction in <italic>norank_f:Ruminococcaceae</italic>, <italic>Gordonibacter</italic>, <italic>Phascolarctobacterium</italic> and <italic>Paludicola</italic>; and the increase in <italic>Bifidobacterium</italic>, <italic>UCG-004</italic>, <italic>Dietzia</italic>, <italic>Turicibacter</italic>, <italic>Romboutsia</italic>, <italic>Candidatus_Saccharimonas</italic>, <italic>Clostridium_sensu_stricto_1</italic>, <italic>Aerococcus</italic>, <italic>Enterorhabdus</italic>, <italic>Muribaculum, Bacteroides_pectinophilus_group</italic>, <italic>Corynebacterium</italic>, etc. Notably, <italic>Allobaculum</italic> in phylum <italic>Firmicutes</italic> is a beneficial bacterium correlated with short-chain fatty acid (SCFA) levels (<xref ref-type="bibr" rid="B58">58</xref>) and plays a protective anti-inflammatory role by increasing the levels of SCFAs in the intestine, regulating human metabolism and immunity and protecting intestinal barrier function (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>). <italic>Faecalitalea</italic> in phylum <italic>Firmicutes</italic> could also be considered a beneficial bacterium since it can ferment D-glucose, sucrose, D-mannose and raffinose into butyric acid (<xref ref-type="bibr" rid="B61">61</xref>), promote postprandial insulin secretion and improve the insulin response in diabetic patients (<xref ref-type="bibr" rid="B59">59</xref>). Among the differential genera that significantly enriched in the SAP group, <italic>Turicibacter</italic> is considered a potential pathobiont that positively regulates the associations of unbalanced dietary intake with constipation and total gastrointestinal symptoms in children with autism spectrum disorder (<xref ref-type="bibr" rid="B62">62</xref>). <italic>Turicibacter</italic> can also modify host bile acid metabolism (<xref ref-type="bibr" rid="B63">63</xref>), the disorder of which could contribute to the pathogenesis of gastrointestinal diseases (<xref ref-type="bibr" rid="B64">64</xref>). In addition, <italic>Turicibacter</italic> is also associated with other neurological disorders, such as depression and Parkinson&#x2019;s disease (<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B66">66</xref>). Both <italic>Dietzia</italic> and <italic>Corynebacterium</italic> belong to the phylum <italic>Actinobacteriota</italic> and are considered opportunistic pathogens (<xref ref-type="bibr" rid="B67">67</xref>). <italic>Muribaculaceae</italic> can degrade mucins in the mucus layer and use mucus-derived sugars as crucial nutrients in the gut (<xref ref-type="bibr" rid="B68">68</xref>). <italic>Clostridium_sensu_stricto_1</italic> is also regarded as an opportunistic pathogen that causes inflammation, pediatric diarrhea and mucosal injury in the gut (<xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B70">70</xref>). Furthermore, some beneficial bacteria, such as <italic>Bifidobacterium</italic>, are enriched in <italic>Kp</italic>-induced SAP rats, which probably reflects the self-regulatory effect to antagonize the gut microbiota dysbiosis, metabolism and immune disorders, as well as other pathological changes, caused by SAP.</p>
<p>In this study, we also observed a profound alteration in the fecal metabolic profile of <italic>Kp</italic>-induced SAP rats, which was characterized mainly by abnormal sphingolipid metabolism, especially elevated ceramide levels; increased neurotoxic QA levels; and upregulation of the Trp&#x2013;serotonin&#x2013;melatonin pathway. Sphingolipids are a complex family of compounds that share a common sphingoid base backbone. In addition to serving as vital structural components of the cell membrane, sphingolipids have also been shown to participate in a series of important biological processes, such as cell proliferation, death, adhesion and migration, autophagy, the cell cycle, inflammation, immune responses, angiogenesis, nutrient uptake, metabolism and cellular signaling (<xref ref-type="bibr" rid="B71">71</xref>). Dysregulation of sphingolipid metabolism is strongly associated with the development of various diseases, including cancer, diabetes, inflammatory diseases, neurodegenerative diseases, cardiovascular and cerebrovascular diseases (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B72">72</xref>&#x2013;<xref ref-type="bibr" rid="B75">75</xref>). Among the sphingolipid family members, ceramides are considered central bioactive molecules in sphingolipid metabolism and important second messengers in cellular signal transduction (<xref ref-type="bibr" rid="B72">72</xref>). Currently, a growing body of preclinical and clinical evidence supports alterations in sphingolipid profiles, especially ceramide levels, in ischemic stroke patients (<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B76">76</xref>&#x2013;<xref ref-type="bibr" rid="B79">79</xref>). The abnormally elevated ceramide levels seem to be significantly correlated with the risk, clinical severity and poor functional outcomes of ischemic stroke (<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>). Several studies also support that the S1P signaling pathway plays a critical role in ICH-induced injury and may be a potential therapeutic target (<xref ref-type="bibr" rid="B77">77</xref>), and ICH patients have increased serum levels of lactosylceramide and decreased levels of phytosphingosine, suggesting that abnormal sphingolipid metabolism seems to be involved in the pathogenesis of ICH (<xref ref-type="bibr" rid="B79">79</xref>); however, alterations in sphingolipid profiles, especially ceramide levels, in subjects with ICH and SAP need to be further elucidated. In this study, we provide the first experimental evidence that the levels of several long-chain ceramides, such as Cer (d18:0/14:0), Cer (d18:1/17:0) and Cer (d18:0/16:0), which are synthesized mainly through abnormal activations of the <italic>de novo</italic>, sphingomyelinase hydrolysis and salvage pathways of sphingolipid metabolism, are upregulated in <italic>Kp</italic>-induced SAP rats, suggesting that abnormal sphingolipid metabolism, especially elevated ceramide levels, may play a critical role in the pathogenesis of SAP.</p>
<p>Trp and its metabolites also participate in regulating a series of important biological processes, such as immunity, metabolism, neurological function and the maintenance of intestinal homeostasis. Aberrant Trp metabolism plays important roles in the pathogenesis of various diseases, including infectious diseases, autoimmune diseases, digestive system diseases, cancers and CNS diseases (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B83">83</xref>). Currently, many preclinical and clinical studies have implicated Trp metabolism in the occurrence and development of ischemic stroke. However, very few studies have investigated the role of Trp metabolism in the pathogenesis of ICH and SAP (<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B84">84</xref>). In this study, we also provide the first experimental evidence that the neurotoxic QA, the downstream product of the Trp&#x2212;kynurenine pathway, was significantly upregulated in <italic>Kp</italic>-induced SAP rats compared to the ICH rats. The elevated QA level we detected in the fecal samples from <italic>Kp</italic>-induced SAP rats might reflect an elevated QA level in the brain. QA is produced mainly by the immune activation of microglia and macrophages in the brain. It can also be synthesized by activated peripheral monocytes, which can enter the brain if the brain barriers are disturbed and contribute to excitotoxicity (<xref ref-type="bibr" rid="B51">51</xref>). QA acts as an N-methyl-D-aspartate (NMDA) receptor agonist and exerts potent neurotoxic and excitotoxic effects by inducing astrocyte apoptosis and neuronal dysfunction. In addition, QA can act as a gliotoxin, proinflammatory mediator, and prooxidant molecule and can alter the integrity and cohesion of the BBB (<xref ref-type="bibr" rid="B85">85</xref>). An abnormally increased QA level may be involved in the pathogenesis of mood disorders and neurodegenerative diseases such as Parkinson&#x2019;s disease and Alzheimer&#x2019;s disease (<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B86">86</xref>).</p>
<p>In addition to the kynurenine pathway, Trp can also be degraded through the serotonin pathway, through which Trp is metabolized into serotonin and its downstream products, such as melatonin and 5-methoxyindoleacetate (<xref ref-type="bibr" rid="B50">50</xref>). In this study, we found that the levels of serotonin and melatonin metabolites, including 3-hydroxymelatonin, 6-hydroxymelatonin and acetyl-N-formyl-5-methoxykynurenamine, were significantly increased in <italic>Kp</italic>-induced SAP rats, whereas the level of 5-hydroxyindoleacetylglycine was significantly decreased, suggesting that SAP induced a significant upregulation of the Trp&#x2013;serotonin&#x2013;melatonin pathway. Among the differentially abundant metabolites mentioned above, serotonin (5-hydroxytryptophan, 5-HT) is a multifunctional signaling molecule that is produced mainly by enterochromaffin cells residing in the intestinal mucosa (<xref ref-type="bibr" rid="B87">87</xref>). In addition to serving as the precursor for melatonin synthesis (<xref ref-type="bibr" rid="B88">88</xref>), serotonin also plays a pivotal role in regulating gastrointestinal motility, secretion, sensation, intestinal barrier function and inflammation (<xref ref-type="bibr" rid="B57">57</xref>). Dysregulation of the serotonin system is associated with various functional gastrointestinal disorders, such as irritable bowel syndrome, Crohn&#x2019;s disease, and ulcerative colitis (<xref ref-type="bibr" rid="B89">89</xref>). Thus, suppressing the biosynthesis of mucosal serotonin seems to be a promising strategy to alleviate inflammation and gastrointestinal disorders. In addition, the differentially abundant metabolites N-acetyl-N-formyl-5-methoxykynuramine, 6-hydroxymelatonin and 3-hydroxymelatonin are produced mainly via the metabolic oxidation of melatonin and are regarded as more stable and effective free radical scavengers (<xref ref-type="bibr" rid="B90">90</xref>&#x2013;<xref ref-type="bibr" rid="B92">92</xref>). 6-Hydroxymelatonin is the principal melatonin metabolite and has been shown to be neuroprotective since it can alleviate singlet oxygen- and QA-induced superoxide anion generation and oxidative damage in rat hippocampal homogenates (<xref ref-type="bibr" rid="B92">92</xref>). In addition, 6-hydroxymelatonin is able to protect rat liver homogenates from iron-induced lipid peroxidation and tissue injury (<xref ref-type="bibr" rid="B93">93</xref>). After ICH, the lysis of erythrocytes increases the iron content and leads to iron overload, which induces toxic hydroxyl radical production and lipid peroxidation and contributes to perihematomal destruction (<xref ref-type="bibr" rid="B94">94</xref>). We speculate that the upregulation of melatonin metabolites, especially 6-hydroxymelatonin, may also reflect the self-regulatory mechanism by which <italic>Kp</italic>-induced SAP rats antagonize ICH-induced iron toxicity, lipid peroxidation, and QA-induced neurotoxicity and excitotoxicity.</p>
<p>Stroke and SAP lead to significant alterations in the gut microbiota in both clinical and animal studies, and gut bacteria potentially influence the metabolism and inflammation of the host through the synthesis of various neurotransmitters, neuropeptides, neurotoxic metabolites, SCFAs, indoles and bile acids that enter the systemic blood and travel to local organs to modulate the BBB, mucosal barriers and functions of neurons and immune cells (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B57">57</xref>). In this study, we observed that the reduction or depletion of some beneficial bacteria, such as <italic>Allobaculum</italic> and <italic>Faecalitalea</italic>, and the increase in several opportunistic pathogens, such as <italic>Turicibacter</italic>, <italic>Dietzia</italic>, <italic>Corynebacterium</italic>, <italic>and Clostridium_sensu_stricto_1</italic>, are associated with disordered sphingolipid and Trp metabolism in <italic>Kp</italic>-induced SAP rats. Previous studies have shown that the gut microbiota can regulate ceramide metabolism (<xref ref-type="bibr" rid="B95">95</xref>), and <italic>Lactobacillus</italic> has been reported to be negatively correlated with serum ceramide and sphingomyelin levels in high-fat diet-fed mice (<xref ref-type="bibr" rid="B96">96</xref>). Our study provides new experimental evidence that some special bacteria can also regulate sphingolipid metabolism, especially ceramide levels. In addition, some special bacteria and their metabolites have been revealed to mediate the synthesis and metabolism of serotonin in the host, and changes in serotonin levels induced by the gut microbiota can modulate the host immune response and subsequently influence the coping strategy adopted by the host to defend against pathogens or disease (<xref ref-type="bibr" rid="B97">97</xref>&#x2013;<xref ref-type="bibr" rid="B100">100</xref>). In turn, intestinal serotonin can promote the colonization of some spore-forming bacteria, such as <italic>Turicibacter</italic>, in the gut, which were previously reported to promote host serotonin biosynthesis (<xref ref-type="bibr" rid="B101">101</xref>). Consistent with this study, we also observed the upregulation of both <italic>Turicibacter</italic> and serotonin levels in <italic>Kp</italic>-induced SAP rats (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>); however, the underlying mechanism of action still needs to be further investigated.</p>
<p>Our study has several limitations. First, we only characterized several pathological features of SAP in these two experimental SAP models at a single time point. Dynamic changes need to be explored to better understand the pathogenesis and provide clues for the optimal timing of interventions for SAP patients. Second, we mainly focused on investigating pneumonia, lung injury and systemic inflammation in these two experimental SAP models, whereas the bacterial loads in the lung, BALF and blood, which were previously evaluated in experimental SAP models of both spontaneous pneumonia after ischemic or hemorrhagic stroke and standardized bacterial pneumonia complicating ischemic stroke (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B21">21</xref>), were not measured in the present study, but will be a future line of investigation in our laboratory. Third, although this study revealed the reduction or depletion of some beneficial bacteria, such as <italic>Allobaculum</italic> and <italic>Faecalitalea</italic>, and the increase in several opportunistic pathogens, such as <italic>Turicibacter</italic>, <italic>Dietzia</italic>, <italic>Corynebacterium</italic>, and <italic>Clostridium_sensu_stricto_1</italic>, in <italic>Kp</italic>-induced SAP rats, which were associated with abnormal sphingolipid metabolism, especially elevated ceramide levels, and disordered Trp metabolism, especially increased neurotoxic QA levels. However, how these differential genera and metabolites participate in regulating a series of important biological processes, such as immunity, neurological function and intestinal homeostasis, which play important roles in the pathogenesis of SAP, still remains to be elucidated. Fourth, we only employed an untargeted metabolomics approach to explore the global fecal metabolic profiles changes and the sphingolipid and Trp metabolism disorders in <italic>Kp</italic>-induced SAP rats, a targeted metabolomics approach will be more appropriate to further verify and exact quantification of the sphingolipid or Trp metabolites. Fifth, the differential genera or the differentially abundant sphingolipid or Trp metabolites we identified in <italic>Kp</italic>-induced SAP rats may not reflect prevailing intestinal flora and metabolite changes in SAP after ICH, additional studies are needed to verify these mechanisms by using Gram-positive bacteria-induced pneumonia, or using clinical SAP samples.</p>
<p>In summary, we present two standardized rat models of post-ICH pneumonia induced by nasal inoculation with 2&#xd7;10<sup>5</sup> CFUs of <italic>Kp</italic> or intratracheal inoculation with 3 mg/kg LPS 3 days after ICH. We first characterized several pathological features of these two models to verify that they are able to duplicate at least some of the mechanisms and consequences of human hemorrhagic stroke and SAP. We provide the first experimental evidence that several long-chain ceramides, the central bioactive molecules involved in sphingolipid metabolism; the neurotoxic quinolinic acid, the downstream product of the tryptophan (Trp)-kynurenine pathway; and the Trp&#x2013;serotonin&#x2013;melatonin pathway are upregulated in <italic>Kp</italic>-induced SAP rats. We further discovered that the dysregulated gut microbiota is associated with disordered sphingolipid and Trp metabolism. Taken together, these two models may be highly useful for investigating the pathogenesis and screening and optimizing potential treatments for SAP. Moreover, the differential genera and sphingolipid or Trp metabolites identified above seem to be promising therapeutic targets.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>Data supporting the findings of this study are available from the last corresponding author upon reasonable request. The sequencing data have been deposited in the NCBI SRA database under the accession number PRJNA1136706.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by Institutional Ethics Committee of Guangzhou University of Chinese Medicine (No. 20210531004) and Guangdong Provincial Hospital of Chinese Medicine (No. 2019060). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>RW: Conceptualization, Formal Analysis, Funding acquisition, Writing &#x2013; original draft. CG: Formal Analysis, Investigation, Writing &#x2013; review &amp; editing. RM: Investigation, Writing &#x2013; review &amp; editing. YC: Formal Analysis, Writing &#x2013; review &amp; editing. RY: Writing &#x2013; review &amp; editing, Conceptualization. GL: Writing &#x2013; review &amp; editing, Resources, Supervision. TX: Writing &#x2013; review &amp; editing, Conceptualization, Supervision. JG: Supervision, Writing &#x2013; review &amp; editing, Conceptualization, Funding acquisition, Project administration, Writing &#x2013; original draft.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study received principal funding from the following grants: National Natural Science Foundation of China (No. 81974559), Key-Area Research and Development Program of Guangdong Province (No. 2020B1111100009), Guangzhou Municipal Science and Technology Bureau (Nos. 2024A03J0020, 2024B01J1352, and 202102010287), Guangdong Provincial Key Laboratory of Research on Emergency in TCM (No. 2023B1212060062) and Guangdong Provincial Bureau of Traditional Chinese Medicine Research Project (No. 20225007).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2024.1477902/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2024.1477902/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feigin</surname> <given-names>VL</given-names>
</name>
<name>
<surname>Stark</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>CO</given-names>
</name>
<name>
<surname>Roth</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Bisignano</surname> <given-names>C</given-names>
</name>
<name>
<surname>Abady</surname> <given-names>GG</given-names>
</name>
<etal/>
</person-group>. <article-title>Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019</article-title>. <source>Lancet Neurol</source>. (<year>2021</year>) <volume>20</volume>:<fpage>795</fpage>&#x2013;<lpage>820</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1474-4422(21)00252-0</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krishnamurthi</surname> <given-names>RV</given-names>
</name>
<name>
<surname>Ikeda</surname> <given-names>T</given-names>
</name>
<name>
<surname>Feigin</surname> <given-names>VL</given-names>
</name>
</person-group>. <article-title>Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: A systematic analysis of the global burden of disease study 2017</article-title>. <source>Neuroepidemiology</source>. (<year>2020</year>) <volume>54</volume>:<page-range>171&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000506396</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cordonnier</surname> <given-names>C</given-names>
</name>
<name>
<surname>Demchuk</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ziai</surname> <given-names>W</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>Intracerebral haemorrhage: current approaches to acute management</article-title>. <source>Lancet</source>. (<year>2018</year>) <volume>392</volume>:<page-range>1257&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(18)31878-6</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teh</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Barlas</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Bettencourt-Silva</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>AB</given-names>
</name>
<etal/>
</person-group>. <article-title>Impact of stroke-associated pneumonia on mortality, length of hospitalization, and functional outcome</article-title>. <source>Acta Neurol Scand</source>. (<year>2018</year>) <volume>138</volume>:<fpage>293</fpage>&#x2013;<lpage>300</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ane.12956</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Elevated lactate dehydrogenase predicts pneumonia in spontaneous intracerebral hemorrhage</article-title>. <source>Heliyon</source>. (<year>2024</year>) <volume>10</volume>:<elocation-id>e26109</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e26109</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Badve</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Z</given-names>
</name>
<name>
<surname>van de Beek</surname> <given-names>D</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Hackett</surname> <given-names>ML</given-names>
</name>
</person-group>. <article-title>Frequency of post-stroke pneumonia: Systematic review and meta-analysis of observational studies</article-title>. <source>Int J Stroke</source>. (<year>2019</year>) <volume>14</volume>:<page-range>125&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1747493018806196</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vermeij</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Westendorp</surname> <given-names>WF</given-names>
</name>
<name>
<surname>Dippel</surname> <given-names>DW</given-names>
</name>
<name>
<surname>van de Beek</surname> <given-names>D</given-names>
</name>
<name>
<surname>Nederkoorn</surname> <given-names>PJ</given-names>
</name>
</person-group>. <article-title>Antibiotic therapy for preventing infections in people with acute stroke</article-title>. <source>Cochrane Database Syst Rev</source>. (<year>2018</year>) <volume>1</volume>:<fpage>D8530</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/14651858.CD008530.pub3</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shim</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Complex interplay of multiple biological systems that contribute to post-stroke infections</article-title>. <source>Brain Behav Immun</source>. (<year>2018</year>) <volume>70</volume>:<fpage>10</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbi.2018.03.019</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prass</surname> <given-names>K</given-names>
</name>
<name>
<surname>Meisel</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hoflich</surname> <given-names>C</given-names>
</name>
<name>
<surname>Braun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Halle</surname> <given-names>E</given-names>
</name>
<name>
<surname>Wolf</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation</article-title>. <source>J Exp Med</source>. (<year>2003</year>) <volume>198</volume>:<page-range>725&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20021098</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Han</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Dynamic process of secondary pulmonary infection in mice with intracerebral hemorrhage</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>767155</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.767155</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanley</surname> <given-names>D</given-names>
</name>
<name>
<surname>Mason</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Mackin</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Srikhanta</surname> <given-names>YN</given-names>
</name>
<name>
<surname>Lyras</surname> <given-names>D</given-names>
</name>
<name>
<surname>Prakash</surname> <given-names>MD</given-names>
</name>
<etal/>
</person-group>. <article-title>Translocation and dissemination of commensal bacteria in post-stroke infection</article-title>. <source>Nat Med</source>. (<year>2016</year>) <volume>22</volume>:<page-range>1277&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm.4194</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farris</surname> <given-names>BY</given-names>
</name>
<name>
<surname>Monaghan</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>W</given-names>
</name>
<name>
<surname>Amend</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ammer</surname> <given-names>AG</given-names>
</name>
<etal/>
</person-group>. <article-title>Ischemic stroke alters immune cell niche and chemokine profile in mice independent of spontaneous bacterial infection</article-title>. <source>Immun Inflammation Dis</source>. (<year>2019</year>) <volume>7</volume>:<page-range>326&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/iid3.277</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liesz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dalpke</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mracsko</surname> <given-names>E</given-names>
</name>
<name>
<surname>Antoine</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Roth</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>DAMP signaling is a key pathway inducing immune modulation after brain injury</article-title>. <source>J Neurosci</source>. (<year>2015</year>) <volume>35</volume>:<page-range>583&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2439-14.2015</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulte-Herbruggen</surname> <given-names>O</given-names>
</name>
<name>
<surname>Klehmet</surname> <given-names>J</given-names>
</name>
<name>
<surname>Quarcoo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Meisel</surname> <given-names>C</given-names>
</name>
<name>
<surname>Meisel</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Mouse strains differ in their susceptibility to poststroke infections</article-title>. <source>NEUROIMMUNOMODULAT</source>. (<year>2006</year>) <volume>13</volume>:<page-range>13&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000092109</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hufeldt</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Nielsen</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Vogensen</surname> <given-names>FK</given-names>
</name>
<name>
<surname>Midtvedt</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hansen</surname> <given-names>AK</given-names>
</name>
</person-group>. <article-title>Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors</article-title>. <source>Comp Med</source>. (<year>2010</year>) <volume>60</volume>:<page-range>336&#x2013;47</page-range>.</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sundberg</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Schofield</surname> <given-names>PN</given-names>
</name>
</person-group>. <article-title>Living inside the box: environmental effects on mouse models of human disease</article-title>. <source>Dis Model Mech</source>. (<year>2018</year>) <volume>11</volume>:<page-range>3&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/dmm.035360</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochoa-Reparaz</surname> <given-names>J</given-names>
</name>
<name>
<surname>Mielcarz</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Ditrio</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Burroughs</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Foureau</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Haque-Begum</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis</article-title>. <source>J Immunol</source>. (<year>2009</year>) <volume>183</volume>:<page-range>6041&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0900747</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liesz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hagmann</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zschoche</surname> <given-names>C</given-names>
</name>
<name>
<surname>Adamek</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation</article-title>. <source>Stroke</source>. (<year>2009</year>) <volume>40</volume>:<page-range>2849&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/STROKEAHA.109.549618</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prass</surname> <given-names>K</given-names>
</name>
<name>
<surname>Braun</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Dirnagl</surname> <given-names>U</given-names>
</name>
<name>
<surname>Meisel</surname> <given-names>C</given-names>
</name>
<name>
<surname>Meisel</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia</article-title>. <source>STROKE</source>. (<year>2006</year>) <volume>37</volume>:<page-range>2607&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/01.STR.0000240409.68739.2b</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roth</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>V</given-names>
</name>
<name>
<surname>Tiedt</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hundeshagen</surname> <given-names>G</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Post-injury immunosuppression and secondary infections are caused by an AIM2 inflammasome-driven signaling cascade</article-title>. <source>Immunity</source>. (<year>2021</year>) <volume>54</volume>:<page-range>648&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2021.02.004</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mracsko</surname> <given-names>E</given-names>
</name>
<name>
<surname>Stegemann-Koniszewski</surname> <given-names>S</given-names>
</name>
<name>
<surname>Na</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Dalpke</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bruder</surname> <given-names>D</given-names>
</name>
<name>
<surname>Lasitschka</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>A mouse model of post-stroke pneumonia induced by intra-tracheal inoculation with streptococcus pneumoniae</article-title>. <source>Cerebrovasc Dis</source>. (<year>2017</year>) <volume>43</volume>:<fpage>99</fpage>&#x2013;<lpage>109</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000452136</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishore</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Vail</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jeans</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Chamorro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Di Napoli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kalra</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Microbiological etiologies of pneumonia complicating stroke: A systematic review</article-title>. <source>Stroke</source>. (<year>2018</year>) <volume>49</volume>:<page-range>1602&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/STROKEAHA.117.020250</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenberg</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Mun-Bryce</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wesley</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kornfeld</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Collagenase-induced intracerebral hemorrhage in rats</article-title>. <source>Stroke</source>. (<year>1990</year>) <volume>21</volume>:<page-range>801&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/01.str.21.5.801</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>NK</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Karouia</surname> <given-names>F</given-names>
</name>
<name>
<surname>Venkateswaran</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Succession and persistence of microbial communities and antimicrobial resistance genes associated with International Space Station environmental surfaces</article-title>. <source>Microbiome</source>. (<year>2018</year>) <volume>6</volume>:<fpage>204</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40168-018-0585-2</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine</article-title>. <source>Expert Rev Respir Med</source>. (<year>2010</year>) <volume>4</volume>:<page-range>773&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1586/ers.10.71</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sanberg</surname> <given-names>PR</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Willing</surname> <given-names>AE</given-names>
</name>
<etal/>
</person-group>. <article-title>Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats</article-title>. <source>Stroke</source>. (<year>2001</year>) <volume>32</volume>:<page-range>2682&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/hs1101.098367</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delgado</surname> <given-names>P</given-names>
</name>
<name>
<surname>Alvarez</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Santamarina</surname> <given-names>E</given-names>
</name>
<name>
<surname>Molina</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Quintana</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rosell</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Plasma S100B level after acute spontaneous intracerebral hemorrhage</article-title>. <source>. Stroke</source>. (<year>2006</year>) <volume>37</volume>:<page-range>2837&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/01.STR.0000245085.58807.ad</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Marumo</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shibuta</surname> <given-names>H</given-names>
</name>
<name>
<surname>Omura</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Serum S100B, brain edema, and hematoma formation in a rat model of collagenase-induced hemorrhagic stroke</article-title>. <source>Brain Res Bull</source>. (<year>2009</year>) <volume>78</volume>:<page-range>158&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.brainresbull.2008.10.012</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abraham</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Neutrophils and acute lung injury</article-title>. <source>Crit Care Med</source>. (<year>2003</year>) <volume>31</volume>:<page-range>S195&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/01.CCM.0000057843.47705.E8</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grommes</surname> <given-names>J</given-names>
</name>
<name>
<surname>Soehnlein</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Contribution of neutrophils to acute lung injury</article-title>. <source>Mol Med</source>. (<year>2011</year>) <volume>17</volume>:<fpage>293</fpage>&#x2013;<lpage>307</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2119/molmed.2010.00138</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: the new progress</article-title>. <source>Antioxidants (Basel)</source>. (<year>2024</year>) <volume>13</volume>:<page-range>1</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox13010132</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ju</surname> <given-names>M</given-names>
</name>
<name>
<surname>He</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Ulinastatin ameliorates LPS&#x2212;induced pulmonary inflammation and injury by blocking the MAPK/NF&#x2212;kappaB signaling pathways in rats</article-title>. <source>Mol Med Rep</source>. (<year>2019</year>) <volume>20</volume>:<page-range>3347&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2019.10561</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>G</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Gut microbiota dysbiosis induced by intracerebral hemorrhage aggravates neuroinflammation in mice</article-title>. <source>Front Microbiol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>647304</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2021.647304</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>The protective effects of electroacupuncture on intestinal barrier lesions in IBS and UC model</article-title>. <source>Sci Rep</source>. (<year>2023</year>) <volume>13</volume>:<fpage>7276</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-023-34182-z</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Tato</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Joyce-Shaikh</surname> <given-names>B</given-names>
</name>
<name>
<surname>Gulen</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Cayatte</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability</article-title>. <source>Immunity</source>. (<year>2015</year>) <volume>43</volume>:<page-range>727&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2015.09.003</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogawa</surname> <given-names>A</given-names>
</name>
<name>
<surname>Andoh</surname> <given-names>A</given-names>
</name>
<name>
<surname>Araki</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bamba</surname> <given-names>T</given-names>
</name>
<name>
<surname>Fujiyama</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice</article-title>. <source>Clin Immunol</source>. (<year>2004</year>) <volume>110</volume>:<fpage>55</fpage>&#x2013;<lpage>62</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clim.2003.09.013</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kinugasa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sakaguchi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Reinecker</surname> <given-names>HC</given-names>
</name>
</person-group>. <article-title>Claudins regulate the intestinal barrier in response to immune mediators</article-title>. <source>Gastroenterology</source>. (<year>2000</year>) <volume>118</volume>:<page-range>1001&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0016-5085(00)70351-9</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Su</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>N</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Alterations in the gut microbiome and cecal metabolome during klebsiella pneumoniae-induced pneumosepsis</article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>1331</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01331</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname> <given-names>GH</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>QH</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>HD</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>HW</given-names>
</name>
<name>
<surname>He</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Dysbiosis of gut microbiota is an independent risk factor of stroke-associated pneumonia: A chinese pilot study</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2021</year>) <volume>11</volume>:<elocation-id>715475</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.715475</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Gut microbiota composition reflects disease progression, severity and outcome, and dysfunctional immune responses in patients with hypertensive intracerebral hemorrhage</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>869846</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.869846</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="other">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. . doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2020-323263</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Immune regulation of the gut-brain axis and lung-brain axis involved in ischemic stroke</article-title>. <source>Neural Regener Res</source>. (<year>2024</year>) <volume>19</volume>:<page-range>519&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/1673-5374.380869</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durgan</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J</given-names>
</name>
<name>
<surname>McCullough</surname> <given-names>LD</given-names>
</name>
<name>
<surname>Bryan</surname> <given-names>RJ</given-names>
</name>
</person-group>. <article-title>Examining the role of the microbiota-gut-brain axis in stroke</article-title>. <source>STROKE</source>. (<year>2019</year>) <volume>50</volume>:<page-range>2270&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/STROKEAHA.119.025140</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname> <given-names>VK</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bakshi</surname> <given-names>U</given-names>
</name>
<name>
<surname>Cunningham</surname> <given-names>KY</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Lazaridis</surname> <given-names>KN</given-names>
</name>
<etal/>
</person-group>. <article-title>A predictive index for health status using species-level gut microbiome profiling</article-title>. <source>Nat Commun</source>. (<year>2020</year>) <volume>11</volume>:<fpage>4635</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-020-18476-8</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunathilake</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>IJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>YI</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sul</surname> <given-names>WJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Alterations in gastric microbial communities are associated with risk of gastric cancer in a korean population: A case-control study</article-title>. <source>Cancers (Basel)</source>. (<year>2020</year>) <volume>12</volume>:<page-range>6&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers12092619</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Multi-omics reveals specific host metabolism-microbiome associations in intracerebral hemorrhage</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2022</year>) <volume>12</volume>:<elocation-id>999627</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.999627</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamashiro</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>R</given-names>
</name>
<name>
<surname>Urabe</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ueno</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yamashiro</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Nomoto</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke</article-title>. <source>PloS One</source>. (<year>2017</year>) <volume>12</volume>:<elocation-id>e171521</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0171521</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>YS</given-names>
</name>
</person-group>. <article-title>Functional roles of sphingolipids in immunity and their implication in disease</article-title>. <source>Exp Mol Med</source>. (<year>2023</year>) <volume>55</volume>:<page-range>1110&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s12276-023-01018-9</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borodzicz-Jazdzyk</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jazdzyk</surname> <given-names>P</given-names>
</name>
<name>
<surname>Lysik</surname> <given-names>W</given-names>
</name>
<name>
<surname>Cudnoch-Jedrzejewska</surname> <given-names>A</given-names>
</name>
<name>
<surname>Czarzasta</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Sphingolipid metabolism and signaling in cardiovascular diseases</article-title>. <source>Front Cardiovasc Med</source>. (<year>2022</year>) <volume>9</volume>:<elocation-id>915961</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcvm.2022.915961</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Platten</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nollen</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rohrig</surname> <given-names>UF</given-names>
</name>
<name>
<surname>Fallarino</surname> <given-names>F</given-names>
</name>
<name>
<surname>Opitz</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond</article-title>. <source>Nat Rev Drug Discovery</source>. (<year>2019</year>) <volume>18</volume>:<fpage>379</fpage>&#x2013;<lpage>401</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41573-019-0016-5</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busse</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hettler</surname> <given-names>V</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>V</given-names>
</name>
<name>
<surname>Mawrin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hartig</surname> <given-names>R</given-names>
</name>
<name>
<surname>Dobrowolny</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Increased quinolinic acid in peripheral mononuclear cells in Alzheimer&#x2019;s dementia</article-title>. <source>Eur Arch Psychiatry Clin Neurosci</source>. (<year>2018</year>) <volume>268</volume>:<fpage>493</fpage>&#x2013;<lpage>500</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00406-017-0785-y</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chamorro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Urra</surname> <given-names>X</given-names>
</name>
<name>
<surname>Planas</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression</article-title>. <source>Stroke</source>. (<year>2007</year>) <volume>38</volume>:<page-range>1097&#x2013;103</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/01.STR.0000258346.68966.9d</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meduri</surname> <given-names>GU</given-names>
</name>
<name>
<surname>Kohler</surname> <given-names>G</given-names>
</name>
<name>
<surname>Headley</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tolley</surname> <given-names>E</given-names>
</name>
<name>
<surname>Stentz</surname> <given-names>F</given-names>
</name>
<name>
<surname>Postlethwaite</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome</article-title>. <source>Chest</source>. (<year>1995</year>) <volume>108</volume>:<page-range>1303&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1378/chest.108.5.1303</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grommes</surname> <given-names>J</given-names>
</name>
<name>
<surname>Soehnlein</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Contribution of neutrophils to acute lung injury</article-title>. <source>Mol Med</source>. (<year>2011</year>) <volume>17</volume>:<fpage>293</fpage>&#x2013;<lpage>307</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2119/molmed.2010.00138</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mjosberg</surname> <given-names>J</given-names>
</name>
<name>
<surname>Rao</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Lung inflammation originating in the gut</article-title>. <source>SCIENCE</source>. (<year>2018</year>) <volume>359</volume>:<page-range>36&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.aar4301</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuijt</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Lankelma</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Scicluna</surname> <given-names>BP</given-names>
</name>
<name>
<surname>de Sousa</surname> <given-names>EMF</given-names>
</name>
<name>
<surname>Roelofs</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>de Boer</surname> <given-names>JD</given-names>
</name>
<etal/>
</person-group>. <article-title>The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia</article-title>. <source>Gut</source>. (<year>2016</year>) <volume>65</volume>:<page-range>575&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2015-309728</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>New insights into stroke prevention and treatment: gut microbiome</article-title>. <source>Cell Mol Neurobiol</source>. (<year>2021</year>) <volume>42</volume>:<page-range>455&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10571-021-01047-w</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mei</surname> <given-names>F</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of a high-collagen peptide diet on the gut microbiota and short-chain fatty acid metabolism</article-title>. <source>J Funct Foods</source>. (<year>2020</year>) <volume>75</volume>:<elocation-id>104278</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jff.2020.104278</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Investigation of gut microbiome changes in type 1 diabetic mellitus rats based on high-throughput sequencing</article-title>. <source>BioMed Pharmacother</source>. (<year>2020</year>) <volume>124</volume>:<elocation-id>109873</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2020.109873</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Yamanishi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sohn</surname> <given-names>J</given-names>
</name>
<name>
<surname>Alekseyenko</surname> <given-names>AV</given-names>
</name>
<name>
<surname>Leung</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences</article-title>. <source>Cell</source>. (<year>2014</year>) <volume>158</volume>:<page-range>705&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2014.05.052</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Maesschalck</surname> <given-names>C</given-names>
</name>
<name>
<surname>Van Immerseel</surname> <given-names>F</given-names>
</name>
<name>
<surname>Eeckhaut</surname> <given-names>V</given-names>
</name>
<name>
<surname>De Baere</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cnockaert</surname> <given-names>M</given-names>
</name>
<name>
<surname>Croubels</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Faecalicoccus acidiformans gen. nov., sp. nov., isolated from the chicken caecum, and reclassification of Streptococcus pleomorphus (Barnes et&#xa0;al., 1977), Eubacterium biforme (Eggerth 1935) and Eubacterium cylindroides (Cato et&#xa0;al., 1974) as Faecalicoccus pleomorphus comb. nov., Holdemanella biformis gen. nov., comb. nov. and Faecalitalea cylindroides gen. nov., comb. nov., respectively, within the family Erysipelotrichaceae</article-title>. <source>Int J Syst Evol Microbiol</source>. (<year>2014</year>) <volume>64</volume>:<page-range>3877&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/ijs.0.064626-0</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Multi-omics analyses demonstrate the modulating role of gut microbiota on the associations of unbalanced dietary intake with gastrointestinal symptoms in children with autism spectrum disorder</article-title>. <source>Gut Microbes</source>. (<year>2023</year>) <volume>15</volume>:<elocation-id>2281350</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2023.2281350</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lynch</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Choy</surname> <given-names>K</given-names>
</name>
<name>
<surname>Faull</surname> <given-names>KF</given-names>
</name>
<name>
<surname>Jewell</surname> <given-names>T</given-names>
</name>
<name>
<surname>Arellano</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Gut microbiota Turicibacter strains differentially modify bile acids and host lipids</article-title>. <source>. Nat Commun</source>. (<year>2023</year>) <volume>14</volume>:<fpage>3669</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-023-39403-7</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuchs</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Trauner</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. (<year>2022</year>) <volume>19</volume>:<page-range>432&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41575-021-00566-7</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barandouzi</surname> <given-names>ZA</given-names>
</name>
<name>
<surname>Starkweather</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Henderson</surname> <given-names>WA</given-names>
</name>
<name>
<surname>Gyamfi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cong</surname> <given-names>XS</given-names>
</name>
</person-group>. <article-title>Altered composition of gut microbiota in depression: A systematic review</article-title>. <source>Front Psychiatry</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>541</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpsyt.2020.00541</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Lyu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Analysis of the gut microflora in patients with parkinson&#x2019;s disease</article-title>. <source>Front Neurosci</source>. (<year>2019</year>) <volume>13</volume>:<elocation-id>1184</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnins.2019.01184</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koerner</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Goodfellow</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>AL</given-names>
</name>
</person-group>. <article-title>The genus Dietzia: a new home for some known and emerging opportunist pathogens</article-title>. <source>FEMS Immunol Med Microbiol</source>. (<year>2009</year>) <volume>55</volume>:<fpage>296</fpage>&#x2013;<lpage>305</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1574-695X.2008.00513.x</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname> <given-names>FC</given-names>
</name>
<name>
<surname>Wasmund</surname> <given-names>K</given-names>
</name>
<name>
<surname>Cobankovic</surname> <given-names>I</given-names>
</name>
<name>
<surname>Jehmlich</surname> <given-names>N</given-names>
</name>
<name>
<surname>Herbold</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>KS</given-names>
</name>
<etal/>
</person-group>. <article-title>Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization</article-title>. <source>Nat Commun</source>. (<year>2020</year>) <volume>11</volume>:<fpage>5104</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-020-18928-1</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Li</surname> <given-names>LQ</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>T</given-names>
</name>
<name>
<surname>She</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ai</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>ZL</given-names>
</name>
</person-group>. <article-title>Autoinducer-2 may be a new biomarker for monitoring neonatal necrotizing enterocolitis</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2020</year>) <volume>10</volume>:<elocation-id>140</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.00140</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mahfuz</surname> <given-names>S</given-names>
</name>
<name>
<surname>Piao</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Impact of sugar beet pulp and wheat bran on serum biochemical profile, inflammatory responses and gut microbiota in sows during late gestation and lactation</article-title>. <source>J Anim Sci Biotechnol</source>. (<year>2021</year>) <volume>12</volume>:<fpage>54</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40104-021-00573-3</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannun</surname> <given-names>YA</given-names>
</name>
<name>
<surname>Obeid</surname> <given-names>LM</given-names>
</name>
</person-group>. <article-title>Sphingolipids and their metabolism in physiology and disease</article-title>. <source>Nat Rev Mol Cell Biol</source>. (<year>2018</year>) <volume>19</volume>:<page-range>175&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrm.2017.107</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Ceramide in cerebrovascular diseases</article-title>. <source>Front Cell Neurosci</source>. (<year>2023</year>) <volume>17</volume>:<elocation-id>1191609</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fncel.2023.1191609</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maceyka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Spiegel</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Sphingolipid metabolites in inflammatory disease</article-title>. <source>Nature</source>. (<year>2014</year>) <volume>510</volume>:<fpage>58</fpage>&#x2013;<lpage>67</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature13475</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jana</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hogan</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Pahan</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death</article-title>. <source>J Neurol Sci</source>. (<year>2009</year>) <volume>278</volume>:<fpage>5</fpage>&#x2013;<lpage>15</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jns.2008.12.010</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iqbal</surname> <given-names>J</given-names>
</name>
<name>
<surname>Walsh</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Hammad</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Hussain</surname> <given-names>MM</given-names>
</name>
</person-group>. <article-title>Sphingolipids and lipoproteins in health and metabolic disorders</article-title>. <source>Trends Endocrinol Metab</source>. (<year>2017</year>) <volume>28</volume>:<page-range>506&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tem.2017.03.005</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ouro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Correa-Paz</surname> <given-names>C</given-names>
</name>
<name>
<surname>Maqueda</surname> <given-names>E</given-names>
</name>
<name>
<surname>Custodia</surname> <given-names>A</given-names>
</name>
<name>
<surname>Aramburu-Nunez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Romaus-Sanjurjo</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Involvement of ceramide metabolism in cerebral ischemia</article-title>. <source>Front Mol Biosci</source>. (<year>2022</year>) <volume>9</volume>:<elocation-id>864618</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmolb.2022.864618</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>N</given-names>
</name>
<name>
<surname>Keep</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xi</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Critical role of the sphingolipid pathway in stroke: a review of current utility and potential therapeutic targets</article-title>. <source>Transl Stroke Res</source>. (<year>2016</year>) <volume>7</volume>:<page-range>420&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12975-016-0477-3</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jiao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ruan</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>The identification of novel stroke-related sphingolipid biomarkers using UPLC-MS/MS</article-title>. <source>Clin Chim Acta</source>. (<year>2024</year>) <volume>552</volume>:<elocation-id>117652</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cca.2023.117652</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>G</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolomic analysis reveals potential biomarkers and serum metabolomic profiling in spontaneous intracerebral hemorrhage patients using UPLC/quadrupole time-of-flight MS</article-title>. <source>BioMed Chromatogr</source>. (<year>2022</year>) <volume>36</volume>:<elocation-id>e5241</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/bmc.5241</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gui</surname> <given-names>YK</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>ZF</given-names>
</name>
<etal/>
</person-group>. <article-title>Plasma levels of ceramides relate to ischemic stroke risk and clinical severity</article-title>. <source>Brain Res Bull</source>. (<year>2020</year>) <volume>158</volume>:<page-range>122&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.brainresbull.2020.03.009</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>CN</given-names>
</name>
<name>
<surname>Chao</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Kuo</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>SC</given-names>
</name>
<etal/>
</person-group>. <article-title>Plasma ceramides are associated with outcomes in acute ischemic stroke patients</article-title>. <source>J Formos Med Assoc</source>. (<year>2022</year>) <volume>121</volume>:<fpage>43</fpage>&#x2013;<lpage>50</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jfma.2021.01.006</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Su</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Tryptophan metabolism in health and disease</article-title>. <source>Cell Metab</source>. (<year>2023</year>) <volume>35</volume>:<page-range>1304&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2023.06.004</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Le</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Tryptophan metabolism in central nervous system diseases: pathophysiology and potential therapeutic strategies</article-title>. <source>Aging Dis</source>. (<year>2023</year>) <volume>14</volume>:<page-range>858&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.14336/AD.2022.0916</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebedeva</surname> <given-names>NV</given-names>
</name>
<name>
<surname>Khrapova</surname> <given-names>EV</given-names>
</name>
<name>
<surname>Kugoev</surname> <given-names>AI</given-names>
</name>
<name>
<surname>Solomonov</surname> <given-names>AP</given-names>
</name>
</person-group>. <article-title>A disorder of serotonin metabolism in patients in the acute period of nontraumatic intracranial hemorrhages</article-title>. <source>Zh Nevrol Psikhiatr Im S S Korsakova</source>. (<year>1996</year>) <volume>96</volume>:<page-range>50&#x2013;2</page-range>.</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guillemin</surname> <given-names>GJ</given-names>
</name>
</person-group>. <article-title>Quinolinic acid, the inescapable neurotoxin</article-title>. <source>FEBS J</source>. (<year>2012</year>) <volume>279</volume>:<page-range>1356&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1742-4658.2012.08485.x</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hestad</surname> <given-names>K</given-names>
</name>
<name>
<surname>Alexander</surname> <given-names>J</given-names>
</name>
<name>
<surname>Rootwelt</surname> <given-names>H</given-names>
</name>
<name>
<surname>Aaseth</surname> <given-names>JO</given-names>
</name>
</person-group>. <article-title>The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases</article-title>. <source>Biomolecules</source>. (<year>2022</year>) <volume>12</volume>:<page-range>5&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biom12070998</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keszthelyi</surname> <given-names>D</given-names>
</name>
<name>
<surname>Troost</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Masclee</surname> <given-names>AA</given-names>
</name>
</person-group>. <article-title>Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function</article-title>. <source>Neurogastroenterol Motil</source>. (<year>2009</year>) <volume>21</volume>:<page-range>1239&#x2013;49</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2982.2009.01370.x</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>CQ</given-names>
</name>
<name>
<surname>Fichna</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bashashati</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Storr</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Distribution, function and physiological role of melatonin in the lower gut</article-title>. <source>World J Gastroenterol</source>. (<year>2011</year>) <volume>17</volume>:<page-range>3888&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3748/wjg.v17.i34.3888</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ala</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system</article-title>. <source>Int Rev Immunol</source>. (<year>2022</year>) <volume>41</volume>:<page-range>326&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/08830185.2021.1954638</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>DX</given-names>
</name>
<name>
<surname>Manchester</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Reiter</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Plummer</surname> <given-names>BF</given-names>
</name>
<name>
<surname>Hardies</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Weintraub</surname> <given-names>ST</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of <italic>in vivo</italic> hydroxyl radical generation</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>1998</year>) <volume>253</volume>:<page-range>614&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/bbrc.1998.9826</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>DX</given-names>
</name>
<name>
<surname>Manchester</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Burkhardt</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sainz</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Mayo</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Kohen</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant</article-title>. <source>FASEB J</source>. (<year>2001</year>) <volume>15</volume>:<page-range>2294&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.01-0309fje</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maharaj</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Maharaj</surname> <given-names>H</given-names>
</name>
<name>
<surname>Antunes</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Maree</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Nyokong</surname> <given-names>T</given-names>
</name>
<name>
<surname>Glass</surname> <given-names>BD</given-names>
</name>
<etal/>
</person-group>. <article-title>6-Hydroxymelatonin protects against quinolinic-acid-induced oxidative neurotoxicity in the rat hippocampus</article-title>. <source>J Pharm Pharmacol</source>. (<year>2005</year>) <volume>57</volume>:<page-range>877&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1211/0022357056424</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maharaj</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Limson</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Daya</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>6-Hydroxymelatonin converts Fe (III) to Fe (II) and reduces iron-induced lipid peroxidation</article-title>. <source>Life Sci</source>. (<year>2003</year>) <volume>72</volume>:<page-range>1367&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0024-3205(02)02405-0</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage</article-title>. <source>Stroke Vasc Neurol</source>. (<year>2019</year>) <volume>4</volume>:<page-range>93&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/svn-2018-000205</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Bi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>P</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites</article-title>. <source>Gut Microbes</source>. (<year>2021</year>) <volume>13</volume>:<fpage>1</fpage>&#x2013;<lpage>27</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2021.1880220</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>K</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>B</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Glucagon-like peptide-1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolism</article-title>. <source>MedComm (2020)</source>. (<year>2023</year>) <volume>4</volume>:<elocation-id>e416</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mco2.416</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yano</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Donaldson</surname> <given-names>GP</given-names>
</name>
<name>
<surname>Shastri</surname> <given-names>GG</given-names>
</name>
<name>
<surname>Ann</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis</article-title>. <source>Indigenous bacteria gut microbiota regulate Host serotonin biosynthesis. Cell</source>. (<year>2015</year>) <volume>161</volume>:<page-range>264&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2015.02.047</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandic</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Woting</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jaenicke</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sander</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sabrowski</surname> <given-names>W</given-names>
</name>
<name>
<surname>Rolle-Kampcyk</surname> <given-names>U</given-names>
</name>
<etal/>
</person-group>. <article-title>Clostridium ramosum regulates enterochromaffin cell development and serotonin release</article-title>. <source>Sci Rep</source>. (<year>2019</year>) <volume>9</volume>:<fpage>1177</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-018-38018-z</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reigstad</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Salmonson</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Rainey</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Szurszewski</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Linden</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Sonnenburg</surname> <given-names>JL</given-names>
</name>
<etal/>
</person-group>. <article-title>Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells</article-title>. <source>FASEB J</source>. (<year>2015</year>) <volume>29</volume>:<page-range>1395&#x2013;403</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.14-259598</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Legan</surname> <given-names>TB</given-names>
</name>
<name>
<surname>Lavoie</surname> <given-names>B</given-names>
</name>
<name>
<surname>Mawe</surname> <given-names>GM</given-names>
</name>
</person-group>. <article-title>Direct and indirect mechanisms by which the gut microbiota influence host serotonin systems</article-title>. <source>Neurogastroenterol Motil</source>. (<year>2022</year>) <volume>34</volume>:<fpage>e14346</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/nmo.14346</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fung</surname> <given-names>TC</given-names>
</name>
<name>
<surname>Vuong</surname> <given-names>HE</given-names>
</name>
<name>
<surname>Luna</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pronovost</surname> <given-names>GN</given-names>
</name>
<name>
<surname>Aleksandrova</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Riley</surname> <given-names>NG</given-names>
</name>
<etal/>
</person-group>. <article-title>Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut</article-title>. <source>Nat Microbiol</source>. (<year>2019</year>) <volume>4</volume>:<page-range>2064&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-019-0540-4</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>